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ABSTRACT 
 
Pauli Keränen 
 
Use of Bioactive Glasses as Porous Implant Surface Inlays, a Laser-Deposited Coating and 
Peri-Implant Bone Graft Extender  
 
Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, 
University of Helsinki, Finland 
Orthopaedic Research Unit, Department of Orthopaedic Surgery and Traumatology, Faculty 
of Medicine, University of Turku, Finland 
Helsinki 2012. 
 
Total hip arthroplasty is an excellent procedure to treat pain and restore function in patients 
with osteoarthritis and related conditions. In primary hip arthroplasty, both cemented and 
cementless techniques can be applied but the attractiveness of biologic fixation is emerging 
over cementing techniques. In revision hip arthroplasties, cementless biologically 
incorporating implants are virtually the only option even in very aged persons, although the 
local healing conditions are compromised because of the deficient bone stock. The number of 
difficult revision surgeries is expected to increase in the future, reflecting the increased life-
expectancy of aged patients with hip arthroplasties. Therefore, there is a major need to seek 
new solutions in the enhancement of osseointegration in revision hip arthroplasties. 
 
In veterinary surgery, cemented hip arthroplasty is an accepted method of treatment for dogs 
with disabling hip diseases, but aseptic loosening remains a serious long-term complication. 
There is also a trend for cementless techniques in canine hip arthroplasties. 
 
Bioactive glasses are a group of surface-active composition-dependent silica-based 
biomaterials. Bioactive glasses have several unique properties enabling them to act as a bone 
graft substitute and as a surface-active coating material of cementless implants. The material 
is not only osteoconductive and osteopromotive, but may even possess angiogenetic and 
antibacterial properties. 
 
This thesis focused on studying the efficacy of bioactive glasses as sintered porous inlays of 
implant surfaces as well as laser-deposited coating materials in the enhancement of implant 
osseointegration. Bioactive glasses were also studied as extenders of bone grafting around a 
cementless implant. The study utilized unloaded and loaded models of implant healing in 
preclinical models. Osseointegration of titanium or CoCr alloy implants was evaluated by 
means of torsional failure testing and histomorphometry.  
 
No significant advantage was achieved in osseointegration with the use of bioactive glasses 
as porous inlays made of sintered microspheres or as a laser-deposited coating. As an 
unexpected adverse event, bioactive granules mixed with morselized bone allograft delayed 
spontaneous weight bearing. When applied as an extender of allogeneic peri-implant bone 
grafting, hard bioactive glass granules could act as a rolling surface and thereby reduce initial 
implant stability. 
 
Keywords: bioactive glass, titanium alloy implant, osseointegration, coating, bone graft 
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TIIVISTELMÄ 
 
Pauli Keränen 
 
Bioaktiivinen lasi luuimplantin pinnoitteena ja luusiirteen osittaisena korvaajana implantin 
ympärillä 
 
Hevos- ja pieneläinlääketieteen osasto, Eläinlääketieteellinen tiedekunta, Helsingin yliopisto 
Ortopedinen tutkimusyksikkö, Ortopedian ja traumatologian klinikka, Lääketieteellinen 
tiedekunta, Turun yliopisto 
Helsinki 2012 
 
Lonkan tekonivelleikkaus on erinomainen toimenpide nivelrikon aiheuttaman kivun hoidossa 
ja leikkaus palauttaa niveleen lähes normaalin toiminnan. Leikkauksissa voidaan käyttää sekä 
sementtikiinnitteisiä että sementöimättömiä tekoniveliä. Viime aikoina suuntaus on ollut 
biologisesti kiinnittyviin sementöimättömiin tekoniveliin. Uusintaleikkauksissa 
sementöimätön lonkan tekonivel on käytännössä ainoa vaihtoehto jopa hyvin iäkkäillä 
potilailla, vaikka heillä on hidastunut luun paraneminen. Tämän takia tarvitaan uusia 
ratkaisuja uusintaleikkauksissa käytettävien tekonivelten paranemisen nopeuttamiseen.  
 
Eläinlääketieteessä on käytössä sementtikiinnitteiset koiran lonkan tekonivelleikkaukset, 
mutta ongelmana on tekonivelten myöhäisirtoaminen. Lonkan sementöimättömät tekonivelet 
ovatkin yleistymässä myös eläinkirurgiassa. 
 
Bioaktiiviset lasit kuuluvat pinta-aktiivisiin piioksidipohjaisiin biomateriaaleihin. Niiden 
kudosominaisuudet riippuvat lasin koostumuksesta. Bioaktiivisilla laseilla on useita 
ominaisuuksia, jotka puoltavat niiden käyttöä luusiirteiden korvikkeina ja mahdollisesti 
luuimplanttien pinnoitemateriaalina. Bioaktiiviset lasit edistävät uudisluun muodostumista ja 
uusien verisuonien kasvua. Niillä voi olla myös bakteerikasvua estäviä vaikutuksia.  
 
Tässä väitöstutkimuksessa selvitettiin bioaktiivisten lasien soveltuvuutta edistämään 
sementöimättömien luuimplanttien kiinnittymistä luuhun. Bioaktiivisista laseista valmistettiin 
mikropalloja, joista tehtiin huokoisia rakenteita edistämään luun kasvua mikrokarhennetun 
implantin pintaan. Tutkimuksessa testattiin bioaktiivisen lasin kiinnittämistä 
mikrokarhennetun implantin pintaan ohuena kerroksena laserilla. Bioaktiivista lasia käytettiin 
myös korvaamaan tavanomaista luunsiirrettä implantin ympärillä. Tutkimuksessa käytettiin 
kuormittamattomia ja kuormitettuja titaani- tai kromikobolttiseoksista valmistettuja 
implantteja, joiden kiinnittymistä luuhun mitattiin biomekaanisesti ja histomorfometrisesti. 
 
Bioaktiiviset lasipinnoitteet eivät edistäneet implanttien kiinnittymistä luuhun. Toisaalta 
bioaktiivisten lasirakeiden käyttö luunsiirteen osittaisena korvaajana ilmeisesti lisäsi 
implantin mikroliikettä luussa kuormituksen aikana. Toimenpide vähensi odottamattomasti 
spontaania varaamista leikatulle raajalle paranemisen alkuvaiheessa.  
 
Avainsanat: bioaktiivinen lasi, tekonivel, pinnoite, luunsiirre 
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ABBREVIATIONS AND DEFINITIONS 
 
A/W GC  Apatite-wollastonite glass-ceramic 
BCP   Biphasic calcium phosphate  
BEI-SEM  Back-scattered electron imaging of scanning electron microscopy 
BG  Bioactive glass 
BMP  Bone morphogenetic protein 
CaP  Calcium phosphate containing compound 
CHA  Carbonated hydroxyapatite 
CT  Computed tomography 
ECM   Extracellular matrix  
EDXA  Energy dispersive X-ray analysis 
FTIR   Fourier transformation infrared spectrometry  
HA  Hydroxyapatite 
MMP   Matrix metalloproteinase 
µQCT   Micro quantitative computed tomography  
PDGF  Platelet-derived growth factor  
PMMA   Polymethylmetacrylate 
pQCT  Peripheral quantitative computed tomography 
QCT  Quantitative computed tomography 
SBF  Simulated body fluid 
SEM  Scanning electron microscopy 
TCP, β-TCP  Tricalcium phosphate, β-tricalciumphosphate 
TGF-β  transforming growth factor beta  
Ti  Titanium 
Ti6Al4V  Titanium alloy 
THA  Total hip arthroplasty 
VEGF   Vascular endothelial growth factors  
 
 
Autograft  Graft obtained from another anatomic site in the same subject 
Allograft  Graft obtained from another subject 
Bioactivity The characteristic of an implant material which allows it to form a 
bond with living tissue 
Bioactive glass Non-crystalline silica-based solid material with the ability to form 
calcium phosphate layer on its surface in vivo 
Bioactive material A biomaterial that is designed to elicit or modulate biological 
activity 
Biocompatibility The ability of a material used in a medical device to perform with 
an appropriate host response in a specific application  
Bioinert Material that induces a minimal level of response from the host 
tissue 
Biomaterial A material intended to interface with biological systems to 
evaluate, treat, augment or replace any tissue, organ or function of 
the body  
Bone remodeling A process where bone gradually alters its morphology in an 
attempt to adapt to any new external load 
Ceramic An inorganic, non-metallic solid prepared by thermal treatment 
and subsequent cooling. Ceramic material may have a crystalline, 
partially crystalline structure or it may be amorphous. 
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Integrins A family of heterodimeric cell adhesion receptors that provide a 
biophysical bridge and a biochemical link between cells and their 
extracellular matrix in osteogenesis. 
Ossification, endochondral  
The bone formation process where cartilage is replaced by bone 
Ossification, intramembranous  
The bone formation process where mesenchymal stem cells 
differentiate directly into osteoblasts that form bone in layers over 
each other 
Osseointegration The biological process by which living bone fuses with the 
biomaterial by the formation of new bone 
Osteoconductivity The ability of a graft to function as a scaffold for ingrowth of new 
bone and sprouting capillaries 
Osteogenicity  The presence of bone-forming cells within the bone graft 
Osteogenesis  The process of laying down new bone material by osteoblasts 
Osteoinduction Bone formation de novo or in non-osseous tissue by the 
stimulation of the phenotypic conversion of undifferentiated cells 
(mesenchymal stem cells) from the surrounding tissues and their 
differentiation into bone-forming osteoblasts 
Silica  Silicon dioxide 
Silicon  The second most common element on Earth 
Sintering Thermal treatment for calcium phosphate ceramics. The sintering 
process removes volatile chemicals and increases crystal size, 
resulting in a porous and solid material 
Stress shielding Effect of the implant with higher Young’s module than bone 
leading to bone resorption by shielding the bone from stress 
Xenocraft  Graft from another species 
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1.  INTRODUCTION 
 
Total hip arthroplasty is highly effective in alleviating symptoms due to end-stage 
osteoarthritis. Reflecting the aging human patient population and increased life expectancy, 
the number of total hip arthroplasties (THA) performed is expected to increase in the near 
future (Kurtz et al. 2005, Skyttä et al. 2011). Similar development is expected in companion 
animal practice. Although improvements in the design of hip prostheses and surgical 
techniques have made THAs possible at an earlier age for osteoarthritic patients, the results 
gained with THA are not permanent. Consequently, the number of difficult revision cases, 
frequently complicated by a periprosthetic fracture, will also multiply.  
 
The great majority of cemented and cementless femoral stems in THA fail because of aseptic 
loosening (Willert and Semlitsch 1996). Wear particles from any source (most commonly 
from bearing surfaces or bone cement) can induce periprosthetic osteolysis, which can lead to 
aseptic loosening (Schmalzried et al. 1992, Dumbleton et al. 2002, El-Warrak et al. 2004, 
Revell 2008). 
 
The attractiveness of biological fixation in THAs is emerging over cementing techniques. 
Recently, the Rizzoli Institute reported a better outcome for uncemented components 
compared with cemented ones (Bordini et al. 2007), although cemented fixation has 
outperformed uncemented fixation in the meta-analyses of THA populations in national 
registers (Morshed et al. 2007).  In uncemented THA, the key issue is the achievement of 
stability, a prerequisite for early implant healing. Uncemented primary THA should allow 
immediate full weight-bearing without significant migration of the components (Ström et al. 
2007). The second key issue is the promotion of biological implant incorporation. Surface 
microroughening and coating with titanium microparticles and/or with hydroxyapatite have 
been shown to be highly effective in the enhancement of osseointegration (Kokubo et al. 
2004). Failure of the osseointegration of femoral stems is uncommon in primary THAs 
(Mäkelä et al. 2010). The need for bioactive hydroxyapatite coating has even been questioned 
in young patients (Paulsen et al. 2007), but the situation is obviously different in the primary 
THAs of aged patients with impaired bone quality (Moritz et al. 2011).    
 
Compared with primary THAs, the clinical circumstances are completely different in revision 
THA.  In patients with a loosened femoral component, the bone stock is frequently deficient 
and unhealthy, creating highly compromised bone healing conditions. Morselized allografts 
have commonly been used in the reconstruction of bone stock loss in revision arthroplasties. 
The use of allogeneic bone grafts has inherent limitations and potential complications (van 
der Donk et al. 2003). Above all, the availability of high-quality allogeneic bone has become 
a limiting factor (Galea et al. 1998). It has been proposed to partly replace the use of 
allogeneic bone grafts with a ceramic bone graft substitute, such as hydroxyapatite, 
hydroxyapatite/tricalcium-phosphonate ceramic, or bioactive glass (Blom et al. 2002, 
Brewster et al. 1999, Grimm et al. 2001). As an additional benefit, ceramic particles mixed 
with morselized allograft may improve the initial component stability. The feasibility of this 
concept has already been confirmed in animal models of impaction grafting with cement 
fixation (Blom et al. 2005, Eldridge 2003). 
 
Bioactive glasses are surface-active, silica-based, synthetic biomaterials that may bond 
chemically with bone (Hench and West 1996, Ducheyne and Qiu 1999, Hench and Polak 
2002). The biological properties of the glasses are composition-dependent (Brink et al. 1997, 
Karlsson and Rönnlöf 1998). Bioactive glasses have several unique properties allowing them 
Introduction 
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to act as a bone graft substitute and as a surface-active coating material in cementless 
implants. The material is not only osteoconductive and osteopromotive, but may even possess 
angiogenetic and antibacterial properties (Day 2005, Zhang et al. 2010).  
 
In this experimental study the efficacy of bioactive glasses in enhancement of bone implant 
incorporation was studied using bioactive glass porous bodies as inlays in implant surface 
grooves or holes or using bioactive glass coating attached by CO2 laser onto the implant 
surface. Bioactive glasses were also studied in the concurrent use of bone graft extender 
packed around bone implants. 
Review of the literature 
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2. REVIEW OF THE LITERATURE 
 
2.1. HISTORY OF HIP PROSTHESES 
 
Charnley started the successful use of hip prostheses on a larger scale in the 1960s. He used 
polymethylmetacrylate (PMMA) for cementing femoral stem and acetabular cup components 
to bone. The femoral stem of the prostheses used in the first total hip arthroplasties (THAs) 
was made of stainless steel. Due to a high number of stem fractures, stainless steel was 
replaced by cobalt chromium (CoCr) alloy. Cobalt chromium alloy is more durable than 
stainless steel and it has good wear resistance. However, it is a very stiff material, and bone 
loss because of mechanical stress shielding around the femoral stem implant was a common 
observation following its use (Huiskes et al. 1992). This led to attempts to produce a more 
flexible stem in order to increase the mechanical loading on bone. Stiffness can be reduced by 
changing the geometric design of the implant and by using materials with a lower elastic 
modulus (Marcellin-Little et al. 2010).  
 
In the 1980s, titanium alloy Ti6Al4V was introduced. This alloy has a much lower elastic 
modulus than stainless steel and cobalt chromium alloys (Ho et al. 1999). Titanium is tough, 
light and corrosion resistant. Its excellent biocompatibility is attributed to the formation of a 
titanium oxide (TiO2) layer on the surface of titanium implant (Brånemark et al. 1969, 
Ochsenbein et al. 2008).  Titanium, however, has low wear resistance and is thus not suitable 
for use on weight-bearing surfaces. On joint surfaces, low friction materials are used. 
Originally, the acetabular cup material in Charnley’s first prostheses was Teflon (PTFE), 
which was later replaced by a higher wear resistant polyethylene. However, ultra-high 
molecular weight polyethylene (UHMWPE) also wears off with time, resulting in the 
production of wear debris. This debris is phagocytosed by macrophages, inducing a process 
that leads to periprosthetic osteolysis and bone stock loss (Goodman et al. 2009). To 
overcome the problem of wear debris production, metal-on-metal joints with wear-resistant 
metal alloy (CoCr alloy) bearing surfaces were developed. Nevertheless, metal ions, which 
can be toxic and teratogenic, can be released from metal surfaces. Ceramics (zirconium) are 
harder materials with less friction that have been used as joint surfaces. This tripology and the 
demands of different stem properties have brought about modular prostheses that also enable 
variation in the prosthesis neck length (Restrepo et al. 2011). 
 
Nowadays, primary total hip replacements are divided into two groups: cemented and 
uncemented. Cemented hip replacement implants are attached by bone cement, PMMA. 
Cemented prostheses are successful in elderly people, but biologically incorporating 
prostheses have gained increasing popularity in primary hip arthroplasties of patients in all 
age groups (McLaughlin and Lee 2010, Mäkelä et al. 2010). Failure in osseointegration of 
primary arthroplasties is a rare problem (Corten et al. 2011). The most common reason for 
revision arthroplasty is mechanical loosening induced by wear particles from bearing 
surfaces. In revision hip replacements, cementless implants are virtually the only option, even 
in very aged persons (Restrepo et al. 2011), although the local healing conditions for implant 
osseointegration are compromised because of a deficient bone stock. The number of difficult 
revision surgeries is expected to increase in the future, reflecting the increased life-
expectancy of aged patients with usually bilateral contemporary hip arthroplasties. There is a 
major need to seek new solutions for the enhancement of osseointegration in revision hip 
arthroplasties among these patients. 
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In veterinary medicine, cemented total hip arthroplasty is an accepted method of treatment in 
dogs with disabling diseases of the hip joint, as reviewed by Schulz (2000). Cementless 
techniques have also emerged for standard clinical use (Guerrero & Montavon 2009). The 
choice of which technique is used is primarily based on the surgeon’s preference and 
experience, and the dog’s age and quality of bone. The procedure, independently of the mode 
of fixation, is demanding and involves a number of postoperative complications (5–30%). 
Aseptic loosening remains a serious long-term complication of cemented hip arthroplasty 
(Bergh et al. 2004). In a recent retrieval study of cemented canine arthroplasties (Skurla et al. 
2005), the rate of aseptic loosening was 63%. 
 
2.2. IMPLANT BIOMATERIAL 
 
Biomaterials are nontoxic natural or synthetic materials that are intended to form an interface 
with biological systems to evaluate, treat, augment or replace any tissue, organ or function of 
the body (Williams 1987). The reaction of the body to the implant is measured as the 
biocompatibility of the material and it is the most important factor to be considered for 
determining implant success (Williams 2008). An ideal bone implant material defined by 
Schmidt et al. (2001) possess a biocompatible chemical composition to avoid an adverse 
tissue reaction, excellent corrosion resistance in the physiological milieu, acceptable strength, 
high resistance to wear and a modulus of elasticity similar to that of bone to minimize bone 
resorption around the implant. The anchorage of a bone implant relies on the formation of 
new bone between the implant and the surface of the old peri-implant bone. The term 
osseointegration was introduced by Brånemark et al. (1964) to describe this intimate 
apposition and interdigitation of bone with a biomaterial. Osseointegration is a prerequisite 
for the long-term clinical success of a bone implant. In the development of orthopedic 
implants the main modifications have been made to implant surface topography, chemistry, 
energy and charge as well as material composition in order to achieve an optimal bone-
implant interface. 
 
The host response induced by the material and its degradation in living tissues are the main 
factors influencing the biocompatibility of the material. Biomaterials that are biotolerant or 
bioinert, such as titanium and cobalt chromium alloy metal implants, induce the formation of 
a dense fibrous capsule around an implant (Goyenvalle et al. 2006, Suska et al. 2008). 
Fibrous encapsulation limits osseointegration and impedes stress distribution at the implant-
bone interface, which increases the risk of interface failure and implant loosening (Viceconti 
et al. 2000). Bioactive materials such as synthetic calcium phosphate bioceramics form bony 
tissue around the implant material, and this leads to the strong integration of bone with the 
implant surface (Paulsen et al. 2007). The integration of an implant into the surrounding 
tissue increases the probability of implant survival. Hence, materials with an appropriate 
surface are essential for the implant to integrate well with the adjacent bone. Bioresorbable 
biomaterials (e.g. resorbable calcium phosphates and composites) are replaced by growing 
tissue, but they should also be able to integrate into surrounding tissues in order to be 
functional. Therefore, their resorption rates and chemical environment should match with the 
host tissue response. 
 
2.3. BIOLOGY OF IMPLANT OSSEOINTEGRATION 
  
The bone healing process is a special form of wound healing that has three phases. The first, 
reactive phase includes a fracture, hematoma and inflammation. The initial inflammation is 
regarded as an activator of fracture healing leading to hematoma vascularization and stem 
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cell recruitment. The second, reparative phase is characterized by callus formation and 
lamellar bone deposition. The third phase is a remodeling phase leading to the rearrangement 
of bony structures by acting forces.  
 
Cellular reactions following implantation and osseointegration of an implant in the peri-
implant bone healing area have been well described (Davies 2003, Marco et al. 2005, Puleo 
and Nanci 1999, Moreo et al. 2009). The surgical procedure of implantation causes tissue and 
vascular trauma, which leads to hemorrhage followed by the activation of the coagulation 
cascade and formation of a blood clot in the peri-implant area. A fibrin network is formed 
into local hematoma (Park and Davies 2000). Platelets aggregate into the blood clot and 
release cytokines and platelet-derived growth factors (PDGFs). The cessation of blood 
circulation caused by implantation trauma leads to local ischemia and necrosis, triggering an 
inflammatory reaction. Neutrophils and macrophages arrive at the site of injury along a 
chemotactic gradient and remove necrotic tissue. The inflammatory cells serve as an ongoing 
source of growth factors. Hypoxic conditions around a healing implant may accelerate the 
release of vascular endothelial growth factor from mesenchymal stem cells (Portier et al. 
2007, Hu et al. 2008) and enhance stem cell migration (Hu et al. 2011).  
 
After implantation, the oxidized implant surface becomes hydrated with water molecules and 
OH- groups are formed. The interaction of water molecules with the implant surface depends 
on the surface properties of the implant such as hydrophilicity and hydrophobicity (Kasemo 
1998). An implant also comes into contact with many different proteins, carbohydrates, lipids 
and ions from blood and extracellular matrix, which become adsorbed to the surface of the 
implant (Sela et al. 2007). Proteins such as fibronectin (Weiss and Reddi 1981, El-Ghannam 
et al. 1995, Gronthos et al. 1997, El-Ghannam et al. 1999), vitronectin, and collagen (Engler 
et al. 2004) bind to the surface of the implant and mediate cell adhesion by binding to cell 
membrane binding proteins, integrins (Albelda and Buck 1990, Ricci et al. 2008, Olivares-
Navarrete et al. 2008). Cell surface receptors in the integrin superfamily (α5β1 integrins for 
fibronectin, α2β1 integrins for collagen type 1) recognize the arginine-glycine-aspartate 
(RGD) sequence of fibronectin or the hexapeptide glycine-phenylalanine-hydroxyproline-
glycine-glutaminic acid-arginine (GFOGER) sequence of collagen absorbed to the implant 
surface and mediate attachment (Pierschbacher and Ruoslahti 1984, Emsley et al. 2000, 
Kundu et al. 2009). Platelet adhesion has been found experimentally to depend on the 
microtopography of the surface, which alters the concentration of proteins adsorbed to the 
implant surface (Nygren et al. 1997a,b, Park et al. 2001). Platelets are activated by surface 
contact (Sela et al. 2007) and release a number of growth factors, such as the platelet-derived 
growth factor (PDGF) and transforming growth factor beta (TGF-β), which stimulate the 
migration and proliferation of bone marrow-derived cells (Kark et al. 2006, Tokunaga et al. 
2008). 
  
The formation of a new peri-implant vascular network, i.e. angiogenesis, starts from intact 
blood vessels of cortical bone or bone marrow (Gerstenfeld et al. 2003, Rowe et al. 1999, 
Einhorn and Lee 2001, Gerber and Ferrara 2000) and is enhanced by vascular endothelial 
growth factors (VEGF) (Furumatsu et al. 2003, Street et al. 2002) from hematoma (Geris et 
al. 2008),  pericytes/mesenchymal stem cells (Tasso et. al 2010, Deckers et al. 2002), and 
differentiating osteoblasts (Raines et al. 2010). Optimal bone healing is dependent on the 
development of an adequate blood flow (Rowe et al. 1999, Einhorn and Lee 2001, Gerber and 
Ferrara 2000).  
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Recent studies suggest that the composition of the absorbed protein layer, which is dictated 
by implant surface properties, can affect the osteoprogenitor cell lineage fate (Le Guillou-
Buffello et al. 2008). Mesenchymal stem cells (osteoprogenitor cells) arising from vascular 
pericytes (Crisan et al. 2008) have been isolated from various tissues; i.e. periosteum, cortical 
bone, bone marrow, and possibly muscle tissues (Gerstenfeld et al. 2003). They migrate 
(invade) among the first cells to colonize the implant surface through the peri-implant clot to 
the area against a concentration gradient of chemotaxic factors, i.e. growth factors and  
cytokines, being attracted by these factors (Schneider and Haugh 2005, Fiedler et al. 2006). 
Migration of the cells is dependent on both chemical (e.g. matrix ligand and cell integrin 
receptor levels) and mechanical (e.g. the stiffness of the substrate) cues from the environment 
(Zaman et al. 2006, Garcia and Reyes 2005). For example, PDGF is able to stimulate the 
expression of VEGF by pericytes and releases mesenchymal stem cells/pericytes from their 
location in active angiogenic sites (Bouletreau et al. 2002, Maes et al. 2010). Mesenchymal 
stem cells may differentiate directly to osteoblasts, which produce extracellular matrix that 
adheres new cells. Mesenchymal stem cells also release growth factors, especially vascular 
endothelial growth factor.  
 
The formation of new bone on the surface depends on the continuous migration of osteogenic 
cells to the surface where they attach, proliferate, and differentiate into osteoblasts. The 
activation of growth factor receptors in mesenchymal stem cells has quite different effects on 
proliferation, migration, and differentiation and is not yet well understood (Olivares-
Navarrete et al. 2011a). The differentiation of osteoprogenitor cells to bone-forming secretory 
osteoblasts is stimulated by osteogenic factors such as Wnt signaling family members 
(Hadjiargyrou et al. 2002, Olivares-Navarrete et al. 2011a), and BMPs (Dimitriou et al. 2005, 
Schmidmaier et al. 2006). Wnt5a signaling has been shown to increase the commitment of 
mesenchymal stem cells to the osteoblast phenotype (Takada et al. 2007, Wall et al. 2009).  
 
Osteoblasts start bone matrix protein (collagen, osteopontin, osteonectin, osteocalcin, 
fibronectin, bone sialoprotein, and BMP) production by beginning to deposit organic osteoid 
(collagen-rich extracellular matrix) over the interfacing bone or/and on the bioactive implant 
surface (Ahn et al. 2006, Lee et al. 2011, Davies 2003). The mineralized bone is formed by 
the deposition of bone minerals (biological apatite that contains minor elements such as 
carbonate, magnesium, and sodium) within the osteoid (Saltman and Strause 1993). Woven 
bone formation rapidly restores continuity. Osteoblasts become trapped in their own matrix, 
which they secrete, and become osteocytes that communicate with each other and with cells 
at the bone surface via cell processes (Palumbo et al. 1990). Woven bone is replaced by 
mature lamellar bone in the next slow phase of bone remodeling. The mechanical properties 
of woven bone are inferior to those of lamellar bone due to the random orientation of 
collagen fibers (Probst and Spiegel, 1997). 
 
Implant incorporation resembles fracture healing (Galante et al. 1971, Bobyn et al. 1980a, 
Harris et al. 1983,). Bone heals by two mechanisms. In intramembranous ossification, bone is 
directly formed by mesenchymal progenitor cells. In endochondral ossification, cartilage is 
first formed and then transformed to bone by the degeneration of chondrocytes and specific 
matrix metalloproteinase (MMP) regulated degradation of cartilage, vascular penetration and 
calcification of the cartilaginous matrix. At the implant-bone interface, new bone always 
grows by apposition, i.e. by the deposition of matrix on a preexisting surface by 
intramembranous bone ingrowth or ongrowth (Hofmann et al. 1997, Bloebaum et al. 1994, 
Linder et al. 1988, Carlsson et al. 1994), although in some experiments the presence of some 
cartilage has been reported (Claes et al. 1998). Depending on implant biocompatibility, bone 
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is laid on preexisting bone, or in the case of a bioactive implant on its surface. An 
osteogenesis process where bone is laid on the bioactive implant surface and then continues 
towards the host bone is described as contact osteogenesis (Davies 2003). In the case of 
distance osteogenesis, bone deposition occurs directly on the surface of the host bone in the 
peri-implant site proceeding from the host bone towards the implant, which then becomes 
surrounded by bone (Davies 2003). In this process, osteoconduction properties of the material 
are less critical, since the bone surface acts as a source of osteogenic cells that do not have to 
migrate until reaching the implant.  
 
The above-described peri-implant bone healing process leads to osseointegration of the 
implant. This is in the case where the implant is well accepted by the body and a bony 
implant interface is formed. If the body rejects the implant by an inflammatory process or 
there is micromotion of the implant, a process leading to the formation of a fibrous tissue 
interface will impede osseointegration. The biological fixation of an implant requires the 
deposition of well structured calcified tissue, which has been seen to begin 10 to 14 days after 
surgery in experimental animal models (Franchi et al. 2007). The time required for initial 
osseointegration of prostheses in humans is estimated to be about three months, and new 
woven bone transforms to stable lamellar bone in 18 to 24 months at the bone-implant 
interface.  
 
2.4. ROLE OF IMPLANT SURFACE IN OSSEOINTEGRATION 
 
Cementless femoral stems represent two types of biological fixation with bone. Porous coated 
femoral stems interlock with femoral bone by bone ingrowth into the porosity of an implant 
surface. This form of fixation is regarded as a graded bond, since from the implant side the 
strength and stiffness gradually decrease towards the bone and from bone side the same is 
seen within bone tissue. Bioactive implant materials may form a direct chemical bond with 
bone (Liu et al. 2004a, Rizzi et al. 2004, Cook et al. 1992a, de Groot et al. 1998). Titanium 
and its alloys, after certain surface treatments as well as coating with calcium phosphates, 
have been able to produce some forms of such a bond (Rahbek et al. 2005, Moroni et al. 
1999). Osseointegration is dictated by implant surface chemistry, topography, roughness, and 
porosity.    
 
2.4.1. Surface chemistry 
 
The development of implants with high corrosion and wear resistance is important. The 
release of metal ions by corrosion and wear may cause allergic and toxic reactions (Hallab et 
al. 2005, Goodman 2007, Sargeant and Goswami 2006). A higher prevalence of metal 
allergies has been suspected in patients with implant failures (Thomas et al. 2009), although 
the risk of complications in metal-allergic patients has been reported as being low (Thyssen et 
al. 2009, Schuh et al. 2008). Cytotoxic metal ions may activate the immune system, leading 
to the release of cytokines by activated macrophages and monocytes (Granchi et al. 1999, Lee 
et al. 1997, Catelas et al. 2003). Metal ions and wear particles forming complexes with local 
proteins induce an allergic response comparable with a delayed-type hypersensivity reaction 
via T-lymphocyte activation (Davies et al. 2005). Corrosion products in the phagocytable 
range (<10 µm) have also been reported as being able to reduce the bacterial killing ability of 
neutrophils (Shanbhag et al. 1992) and to induce toxic effects in phagocytosing cells (Huk et 
al. 2004), and therefore to predispose to implantation site infection.  
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Titanium and its alloys show superior biocompatibility when compared with other alloys 
(Pearce et al. 2008). A very stable passive dense 2–6 nm thick oxidized layer of TiO2 forms 
naturally on the surface of titanium implants (Ochsenbein et al. 2008) and provides good 
corrosion resistance and superior biocompatibility. This oxide film is also very important for 
the osseointegration of the implant, as it is highly hydrophilic and thus exhibits a high surface 
energy. This is seen as increased wettability that improves the interaction between the 
biological environment and implant surface, affecting protein adsorption and thereby 
regulating cell adhesion.  
 
Different surface treatments can significantly change the chemical composition of the 
titanium implant surface (Wieland et al. 2000, Zhao et al. 2005). Certain heat and alkali 
surface treatments (Kim et al. 1996, Li et al. 2004) produce a thickened oxide layer on the 
titanium implant surface and improve its bioactivity and wear resistance. The –OH- and –O-2 
groups in the oxide layer are important for hydroxyapatite formation and thus enhance 
osseointegration (Li et al. 1994, Zhao et al. 2007). Chemical and heat treatments can induce 
bioactive apatite nucleation points on the titanium surface (Kim et al. 1996, Nishiguchi et al. 
2001, Sandrini et al. 2003, Kruba et al. 2005, Rossi et al. 2007, Giavaresi et al. 2008).  
 
2.4.2. Surface topography 
 
The traditional approach has been to modify the titanium implant surface topography by 
mechanical and chemical methods. Mechanical methods such as machining (Lucchini et al. 
1996, Watanabe et al. 2002), grinding, polishing (Barbour et al. 2007), plasma-spraying (Liu 
et al. 2004b), and blasting (Kim et al. 2003, Wennerberg et al. 1995), and chemical methods 
such as acid etching (Cho and Park 2003, Szmukler-Moncler et al. 2004), alkali etching 
(Nishiguchi et al. 1999, Nishiguchi et al. 2003, Kim et al. 1996, Nishiguchi et al. 2001, 
Sandrini et al. 2003, Kruba et al. 2005, Rossi et al. 2007, Giavaresi et al. 2008) and 
anodization (Park et al. 2007, Son et al. 2003) have been used. It is necessary to define the 
surface topography to be able to interpret its effects (Wennerberg and Albrektsson et al. 
2000). Measurement can be performed using scanning electron microscopy (SEM) (Pearce et 
al. 2008), light profilometry (Pearce et al. 2008), and confocal scanning optical microscopy 
(Olivares-Navarrete et al. 2011a). 
 
The structure of the surface topography can be characterized as texture or roughness. Surface 
texture refers to configurations with defined dimensions, such as grooves, dips, or 
projections. A textured surface results in a mechanical interlocking between the implant and 
the surrounding bone (Albrektsson et al. 1981), which is seen as increased mechanical 
strength (Bobyn et al. 1980b) in the implant interface. A microgrooved surface has been 
shown to be able to direct osteblastic growth (Ricci et al. 2008, Grew et al. 2008). In the 
study of Jayaraman et al. (2004), a grooved titanium surface was shown to support 
osteoblastic cell adhesion, proliferation, and extracellular matrix expression better than a 
sandblasted and acid-etched rough surface.  
 
Surface roughness refers to randomly sized and distributed changes in surface topography. 
The scale of surface roughness can vary from millimeters to nanometers. Rougher textures as 
macroporous surfaces in press-fit implants act as a graded bond to bone when ingrown bone 
and porous coating interdigitate into each other. A rough surface allows greater mechanical 
interlocking and gives initial stabilization until bone can grow and attach to the implant 
surface, providing further improvement in implant bonding (Gross and Babovic 2002). It also 
exposes a higher surface area to integration. Although the porous coatings and rough surfaces 
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of an implant provide an immediate scratch fit with the surrounding bone, the final outcome 
of implant osseointegration is greatly dependent on bone ingrowth and ongrowth occurring 
within the first few weeks to months after implantation. Hence, micro-nanotopography is 
important for surface interactions with proteins and ions from blood and extracellular fluids, 
affecting osteoprogenitor cell adhesion and maturation to osteoblasts, and therefore surface 
osseointegration (Gittens et al. 2011).  
 
2.4.2.1. Surface macrotexture 
 
Macrotexture surfaces that have been developed to provide instant stability after press fit 
implantation and long-term stability after bone ingrowth include porous beads, fiber metal 
meshes, grooves, ridges, dentations, slots and holes (Sumner et al. 1992, Kendrick et al. 
1995). These methods give immediate physical fixation to resist micromotion and shear 
stresses on the interface. In addition to providing mechanical interlocking (Gross and 
Babovic 2002), the grooved profile and topography of an implant surface, independent of the 
chemical nature of the implant material, influences osteoblastic cell movement guidance 
(Brunette 1988, Lu and Leng 2003, Ricci et al. 2008, Grew et al. 2008). Macrotextures have 
been used in clinical cementless (Effenberger et al. 2005) and cemented (Nowakowski et al. 
2008) femoral stems in THR prostheses. The danger in these macrotextures is that they can 
act as stress rises, which may cause bone breakage or implant failure (Dorian et al. 2003). 
Hirao et al. (2005) studied the effect of implant surface macrotexture grooves and slots in a 
rabbit model and stated that macrotexture grooves were more important than 
microtopographic features. 
  
2.4.2.2. Surface roughness 
 
The roughness average (Ra, the arithmetic mean deviation of the absolute values of all points 
of the two-dimensional profile, or Sa, the arithmetic mean deviation of a three-dimensional 
surface) is used to characterize implant surface roughness. Roughness is characterized by 
scanning electron microscopy and measured by profilometry (Rupp et al. 2006). Micron-scale 
roughness can be measured by confocal laser microscopy and nanoscale roughness by atomic 
force microscopy (Gittens et al. 2011). 
 
Surface microtopography has been found experimentally to be a determinant factor in 
osteogenesis (Lossdörfer et al. 2004). Surface micro-nanotopography affects protein 
absorption (Webster et al. 2000a) and thus cell adhesion via integrin expression (Raz et al. 
2004) and Wnt signaling (Olivares-Navarrete et al. 2011b), and finally osteoprogenitor cell 
differentiation to osteoblasts (Gittens et al. 2011, Webster et al. 2000b). Surface micro-
nanotopography has demonstrated improved protein adhesion and bone cell responses and 
differentiation in numerous in vitro studies (Itälä et al. 2002, Boyan et al. 2002, Lohmann et 
al. 2002, Park and Davies 2000) as well as superior osseointegration in vivo (Albrektsson et 
al. 1981, Buser et al. 1991, Itälä et al. 2003a,b, Szmukler-Moncler et al. 2004, Ronold and 
Ellingsen 2002, Abron et al. 2001, Sela et al. 2007, Park et al. 2001; Kikuchi et al. 2005, 
Franchi et al. 2007, Guizzardi et al. 2004). Increased bone formation seen in in vivo 
experiments using implants with a micro-nanotopographic rough surface is not only caused 
by enhanced osteoblastic activity but also by decreased bone resorption, since cells produce 
increased levels of factors that inhibit osteoclastic activity, including transforming growth 
factor beta-1 (TGF-β1) and osteoprotegrin (OPG) (Kieswetter et al. 1996, Lossdörfer et al. 
2004, Swartz et al. 2009). 
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Integrin expression in the osteblast is sensitive to surface roughness (Raz et al. 2004).  Rough 
coatings result in a greater number of adhered osteoblasts and higher cell activity (Feng et al. 
2003). However, in dental implants an optimum surface roughness is thought to exist with an 
Sa value between 1–2 µm (Albrektsson and Wennerberg 2004, Wennerberg and Albrektsson 
2011, Ronold et al. 2003).  Thus, it has to be remembered that osseointegration is the sum of 
many factors (including surface topography, chemistry, and energy).  
 
2.4.2.3. Surface porosity 
 
Porous coatings were developed to increase the fixation and stability of implants by bone 
ingrowth, resulting in mechanical interlocking (Bobyn et al. 1980b, Puleo & Nanci 1999). 
Osteoblastic activity has been observed to be significantly greater in the porous coated region 
of an implant (Feng et al.  2003, Boyan et al. 1996) compared with the host bone, possibly 
due to the trauma of implantation or the influence of implant load on the bone tissue, 
promoting a regional acceleratory phenomenon (Bloebaum et al. 2007). Frost (1983) 
described a regional acceleratory phenomenon to be a complex tissue reaction to noxious 
stimuli leading to acceleration of the bone tissue remodeling process that may persist as long 
as the causative stimulus remains. Bone ingrowth into a porous metal implant occurs from the 
periphery of the implant, and a constant decrease in mineralization is seen towards the inside 
(Jones et al. 2007).  
 
Data from retrieval studies on orthopedic implants indicate that only a relatively small 
proportion of the available pore volume is filled with bone (Galante and Jacobs 1992, Cook et 
al. 1988, Engh et al. 1987). Willie et al. (2004) reported that the amount of cancellous bone 
ingrowth over time in a sheep model using a weight-bearing porous coated titanium implant 
in the distal femur was not significantly different from that reported in similarly porous 
coated bilateral total knee arthroplasty implants of older humans (Bloebaum et al. 1994, 
Hoffman et al. 1997).  
 
Microporosity (pore diameter less than 10 µm) allows body fluid circulation and increases 
protein absorption (Yuan et al. 1999). Habibovic et al. (2006) showed that the highly 
microporous one of the two equally macroporous calcium phosphate implants expressed a 
significantly better bone formation ability. Macroporosity (pore diameter more than 50–100 
µm) provides a scaffold for bone growth. Porous implants enhance bone ingrowth compared 
to dense implants in vivo (Overgaard et al. 1998). Calcium phosphate coating enhances bone 
ingrowth in porous metal implants (Cook et al. 1992b, Vehof et al. 2001). A study by 
Klawitter and Hulbert (1971) indicated that a minimum pore size of 45–100 µm is needed for 
bone ingrowth into porous ceramics. No threshold value for new bone ingrowth was found in 
pore sizes ranging from 50 to 125 µm under non-load-bearing conditions in a rabbit model 
(Itälä et al. 2001). The optimal range for pore sizes according to several studies is from 100 
µm to 400 µm (Kiefnapfel and Griss 1998, Bobyn et al. 1980a, Cook et al. 1985), since it will 
provide a better opportunity for vascular support.  
 
Recently, Fukuda et al. (2011) demonstrated the osteoinductive properties of porous titanium 
implants on which a channel structure of four different channel diameters with micro- and 
nanostructured roughness was fabricated by selective laser melting (Pattanayak et al. 2011), 
and bioactivity was created by alkali and heat treatment. The greatest new bone formation 
was observed in the 500 µm channels of the studied 500, 600, 900, and 1200 µm channels in 
an intramuscular titanium implant dog model.  
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2.4.3. Surface coatings 
 
Hydroxyapatite (HA) coatings were originally developed to apply on titanium alloys to 
accelerate the rate of fixation of the implants to the surrounding bone and to improve the 
quality of bone ingrowth (de Groot et al. 1997). The experimental studies of Søballe (1993a) 
demonstrated that hydroxyapatite coating is effective in compensating for the retarding 
effects of an initial gap between bone and implant and the presence of osteopenic host bone. 
Since then, hydroxyapatite coating has become almost a routine adjunct in cementless 
implants and its clinical use has passed 20 years (Chambers et al. 2007).   
 
Hydroxyapatite coatings are osteoconductive and direct contact osteogenesis occurs directly 
onto the HA surface. The resulting direct chemical bond to bone provides for significantly 
higher interfacial attachment strength to host bone than can be achieved with non-coated 
implants. Based on experimental studies of non-weight-bearing implants, reviewed by 
Søballe (1993a), the maximum attachment strength is also obtained in half the time as 
compared with porous coated implants without hydroxyapatite coating.  
 
In vivo, hydroxyapatite coatings undergo compositional and structural changes under 
physiological loading conditions, but the extent of these changes and their influence on the 
integrity of the mechanical coating and implant prognosis are still not completely understood. 
There have been retrieval human implant studies that suggest unexpectedly rapid dissolution 
in a substantial proportion of the hydroxyapatite coating (Porter et al. 2004), and even 
complete degradation (Aebli et al. 2003). The assumed mechanisms of loss of the 
hydroxyapatite coating are osteoclast-mediated degradation, simple dissolution, mechanical 
removal (delamination) and wear (Overgaard et al. 1998).  
  
There is some concern about the long-term effects of hydroxyapatite coating because of the 
risk of degradation, delamination, and third-body wear in the articulation. Most 
hydroxyapatite coatings produced by plasma-spraying techniques are unresorbable and have 
thicknesses ranging from 30 to 200 µm. Thicker layers may be weaker and subject to fatigue 
failure when experiencing sufficient stress under cyclic physiological loads leading to particle 
release and delamination (Yan et al. 2003a,b). Thinner resorbable calcium phosphate coatings 
have been developed, but the coatings are still experimental (Reistad et al. 2011).  
 
The original and still most commonly used technique for hydroxyapatite coating is plasma 
spraying (de Groot et al. 1987), but there are many other coating methods. The high number 
of potential techniques reflects the difficulties in creating a high-quality HA coating. There is 
also a possibility to tailor hydroxyapatite properties through changes in the chemical 
composition and microstructure. Different coating techniques and processing conditions 
cause variability in the properties of commercially available hydroxyapatite coatings (Gross 
et al. 2010).  
 
A current opinion is that the advantages of hydroxyapatite coating are superior proximal 
femoral osseointegration, a reduced subsidence risk and better preservation of periprosthetic 
bone quality (Chambers et al. 2007). Improved osseointegration of coated implants may also 
serve as an added barrier to the migration of particulate debris (Tanzer et al. 2004), and there 
is considered to be sufficient data to support the routine use of hydroxyapatite coating, 
although it has not been shown to significantly increase long-term durability. However, 
conflicting results have recently been presented. Paulsen et al. (2007) reported results from 
the Danish Hip Arthroplasty Registry that demonstrated no reduction in the risk of revision 
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surgery after primary total arthroplasty with hydroxyapatite coating. A meta-analysis showed 
neither clinical nor radiological benefits of the application of a hydroxyapatite coating on a 
femoral component in uncemented primary total hip arthroplasty (Goosen et al. 2009).  
 
The emerging concept of so-called biomimetic coating is based on the use of biomolecules to 
increase the adhesiveness of the implant surface for osteoblasts or to promote differentiation 
of attached mesenchymal stem cells. The biomolecules used can be extracellular matrix 
proteins and peptides that mediate cell adhesion, such as arginine-glycine-aspartic (RGD), 
which is a small peptide ligand with a high affinity for integrins of bone extracellular matrix 
(Ferris et al. 1999, Elmengaard et al. 2005). The biomimetic coating can be combined with 
antimicrobial drugs (Alt et al. 2011). Growth factors have also been applied in biomimetic 
coatings (Lind et al. 1996), but the results from the application of recombinant growth 
factors, such as BMPs, have not been promising. The difficulty in use of growth factors and 
antibiotics is that they should not be released from the surface of an implant in an 
uncontrollable single burst, but instead there should be a sustained release system. 
 
Bioactive glasses are attractive for use as a bioactive coating of implants because of their 
rapid direct bonding with new bone (Hench 2009), and they appear to induce a high turnover 
of the attached new bone (Välimäki et al. 2006) and stimulate angiogenesis (Day et al. 2005, 
Leu et al. 2009).  
 
There have been numerous attempts to coat metallic implants with bioactive glass using 
enameling (Gomez-Vega et al. 1999, Lopez-Esteban et al. 2009), rapid immersion in molten 
glass (Lacefield and Hench 1986), plasma spraying (Kitsugi et al. 1996, Wheeler et al. 2001), 
ion beam sputtering (Wang et al. 2002), sol-gel techniques (Durán et al. 2004), and CO2 
lasers (Moritz et al. 2004a, Comesãna et al. 2010, Borrajo et al. 2007).  Despite early positive 
result (Griss et al. 1976), bioactive glass has failed as a conventional surface coating material 
of titanium implants in experimental studies (Lopez-Sastre et al. 1998) and also in primary 
THA patients (Alonso-Barrio et al. 2004). As with any glass, the amorphous structure of 
bioactive glass impairs the mechanical strength of the material and its fracture toughness. The 
brittleness of bioactive glass restricts its use for load-bearing applications (Karlsson and Hupa 
2008). The thermal expansion coefficient of  Bioglass® is 15.1 x 10-6 K-1 and for Ti6Al4V 
9.6 x 10-6 K -1 between 200–400 °C (Gomez-Vega et al. 2001). Because of this discrepancy in 
the thermal expansion rate of glass, coatings are at risk of cracking and delamination at the 
glass–metal interface (Gomez-Vega et al. 1999). Although the thermal expansion of bioactive 
glasses can be manipulated by changing the contents of silica and other oxides in the glass 
(Lopez-Esteban et al. 2003), and some coatings with excellent in vitro behavior have been 
obtained, most of the glass coatings have been damaged by cracking and poor reliability at 
the glass–metal interface (Hench 1998, Kitsugi et al. 1996). The poor mechanical behavior of 
bioactive glasses could be improved by using it intertwined into a surface of a tougher 
material, as has already been done in scaffolds for guided bone regeneration in regard to their 
osteoconductive properties incorporated into polymer composites (Maquet et al. 2004). 
 
2.5. BIOMECHANICS OF IMPLANT INCORPORATION 
 
Primary stability in clinical implants depends on implant design (cross-sectional geometry, 
mode of additional fixation, and mismatch in implant-bone stiffness), the surgical 
implantation technique and patient variables (bone quality, bone stock deficiencies). The 
initial stability of the implant can be increased by underreaming the bone bed for the implant, 
creating a press-fit, and by using adjunctive physical methods of fixation such as roughened 
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surfaces on the implant, pegs, screws, grooves, and spines. The primary stability is an 
important determinant for the amount of bone ingrowth into a loaded implant (Kiefnapfel and 
Griss 1998). Early osseointegration by bone ingrowth prevents the subsidence of a loaded 
implant and ensures longevity of the implant. Moderate mechanical stimulation of cells 
enhances osseointegration (Rubin and McLeod 1994, Willie et al. 2010), but excessive levels 
of stress induce the formation of a non-desirable fibrous tissue around the implant (Jones et 
al. 1995, Jasty et al. 1997). Without a perfect implant fit, weight bearing leads to interface 
micromotion, resulting in the formation of fibrous tissue that encapsulates the implant in the 
bone-implant interface. Fluid velocity and maximal distortional strain are considered as the 
stimuli that guide the differentiation process of mesenchymal cells into fibroblasts, 
chondrocytes, or osteoblasts (Geris et al. 2004), as was shown in experimental studies with a 
repeated sampling bone chamber implanted in the proximal tibiae of adult rabbits (Tagil and 
Aspenberg 1999, Moalli et al. 2000) and in a cancellous bone rabbit model (Willie et al. 
2010). Excessively high mechanical loading favors the differentiation of mesenchymal stem 
cells towards fibroblasts and severely endangers bone formation (Prendergast et al. 1997, 
Carter et al. 1998, Claes et al. 1998). The relation between excessive early micromotion and 
the formation of a fibrous capsule instead of bony osseointegration in the implant-bone 
interface has been extensively studied (Pilliar et al. 1986, Søballe et al. 1992a,b, Brunski 
1999, Mouzin et al. 2001, Cullinane et al. 2003). Initial interfacial micromotion greater than 
about 50-100 µm is shown to inhibit bone ingrowth (Pilliar et al. 1986, Søballe et al. 1992b, 
Jasty et al. 1997). Excessive interfacial micromotion interferes with angiogenesis, the 
formation of a vascular network, and thereby inhibits bone formation (Fång et al. 2005). 
 
Peri-implant adaptive bone remodeling depends on the mechanical loading of bone, affecting 
the functional life span of the implant. Optimal loading conditions of an implant lead to the 
remodeling of surrounding bone and thereby to increased stability of an implant. Strain (ϵ = 
ΔL/L) is a measure to quantify mechanical deformations in bone and is expressed as the 
change in length divided by the original length of any given specimen. According to Wolff’s 
law, the mechanostat system controls bone mass variation by keeping the peak mechanical 
strain within an acceptable range. Mechanical loading enhances bone remodeling in response 
to physiological stress, but a lack of appropriate stress will cause bone loss. Osteocytes are 
thought to work as a sensory network to sense and respond to strain (Rubin et al. 2002), fluid 
flow (Lee et al. 2008), and unloading (Gross et al. 2005). Osteoblasts sense mechanical 
stimuli by mechanosensors such as integrins, which are membrane-spanning proteins that 
connect a cell to the extracellular environment, initiating intracellular and extracellular 
signaling pathways upon binding (Lee et al. 2010, Young et al. 2009). Hence, the adaptive 
responses of bone to a metal implant can change the periprosthetic bone mass and 
morphology. Periprosthetic adaptive bone remodeling after total hip arthroplasty can be 
predicted with finite element analyses (Van Rietbergen et al. 1993). 
 
The metal implants used today are stiffer than bone, preventing the stress transfer to adjacent 
bone that is necessary for bone maintenance. The implantation of the femoral cavity with a 
metal femoral component of a hip prosthesis alters the strain distribution within the 
surrounding bone, leading to bone resorption seen mainly in the calcar and proximal medial 
cortical wall area, and to increased periosteal bone formation in some areas, depending on the 
implant design (Goodship et al. 2008). This phenomenon of bone loss caused by a weight-
bearing implant is termed the stress shielding effect (Sumner et al. 1998) and leads to bone 
resorption around an implant and consequently to implant loosening. To avoid loosening of 
implants and revision surgery, materials with an excellent combination of high strength and 
low modulus closer to bone that are well balanced to avoid stress-shielding but stiff enough 
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to prevent excessive micromotion have to be developed for implantation (Tarala et al. 2011). 
As in human orthopedics (Akhavan et al. 2006), low-modulus stems (Marcellin-Little et al. 
2010) have been introduced to overcome the stress shielding effect, but the clinical proof of 
their efficacy is still incompletely known. 
  
The mechanical strength of implant incorporation in experimental studies is measured by 
pushout (Borsari et al. 2007, 2009), pullout (Sachse et al. 2005, Moritz et al. 2011) or 
torsional testing (Yan et al. 2003a). For the pushout or pullout test, it is easy to calculate a 
comparable numeric value by dividing the force (N) needed to dislocate an implant by the 
area (m2) of the implant’s surface attached to bone. The equation gives the bonding strength 
in the unit N/m2 = Pa (pascal). The unit of torque strength is Nm and it is specific to certain 
implant and testing conditions, which make the comparison between different studies more 
difficult, as normalization against the bone-implant contact area is not always possible. In 
prosthesis studies, torque testing is nevertheless considered more appropriate, since getting 
up from a chair or walking up stairs creates considerable harmful torsional micromotion 
forces on femoral stems (Bergmann et al. 1995, Kassi et al. 2005), and torsional stability is 
important for the femoral stem (Monti et al.1999). In addition, cyclic fatigue tests are used to 
study the implant and coating life span under a cyclic load of a certain amplitude and 
frequency (Zhang et al. 2001). 
 
2.6. BONE GRAFTING AND BONE GRAFT SUBSTITUTES 
 
Bone grafts are classified according to tissue origin. Autografts come from the same 
individual. Allografts are derived from different individuals of the same species. Xenografts 
are derived from individuals of different species. Bone grafts can also be classified according 
to the type of tissue: cancellous or cortical, and structural or nonstructural grafts. Bone grafts 
are additionally classified as fresh (with viable cells), vascularized (the main blood vessels of 
grafts are joined to recipient vasculature to provide the graft with blood circulation), and 
preserved.  
 
Bone grafting must be carefully planned according to the site and size of bone defect and 
considering mechanical demands. When bone grafting is performed, it is imperative to 
prepare a viable graft bed. This requires the excision of fibrous scar tissue, the treatment of 
infection, an adequate blood supply, and soft tissue coverage (Sandhu et al. 1999).  
 
2.6.1. Autografts 
 
Ideal bone graft materials exhibit supreme characteristics of osseointegration, 
osteoconduction, osteoinduction and osteogenesis. Autogenous bone containing vital cells 
fulfills these requirements (Silber et al. 2003, Pape et al. 2010). Commonly, an autograft is 
retrieved from cortico-cancellous bone of the iliac bone. In veterinary surgery, cancellous 
grafts are retrieved from the proximal humerus and the proximal tibia.  
 
An autograft can also be a strut graft from a fibular bone, rib bone or ileal crest. These can be 
taken as a vascular graft. The obtained bones are typically small in size and weak for load 
bearing. An autograft is osteoinductive, since osteoclastic activity liberates growth factors 
from the bone graft matrix which enhances bone formation (Cypher and Grossman 1996, 
Schmidmaier et al. 2006). In cancellous bone grafts, the trabecular structure has a large 
surface area for a high number of osteoprogenitor cells, providing the graft with excellent 
osteogenic and osteoinductive capabilities (Schmidmaier et al. 2006). 
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After the grafting procedure, hemorrhaging and an inflammatory reaction are seen in the graft 
area. The graft becomes fixed with a fibrinous network. Osteogenic cells on the surface of 
autograft survive by diffusion and start to synthesize new bone on the graft. Most osteocytes 
die, but some osteoblasts and osteoclasts can survive in fresh grafts. The grafting process 
initiates an inflammatory process at the site, leading to the release of cytokines. In the first 
few days, revascularization of a cancellous graft takes place and new osteogenic and 
osteoclastic cells migrate to the site. The graft-derived growth factors induce increased bone 
turnover. New immature woven bone is rapidly synthesized on the graft bone, which is seen 
as increased radiodensity in radiographs. The remodeling and complete replacement of the 
nonviable graft bone follows according to Wolff’s law. Cancellous autografts become 
completely resorbed and replaced by new host bone within a year (Khan et al. 2005). 
Resorption by osteoclastic activity always renders cancellous and cortical bone grafts 
mechanically weaker until new bone production has time to strengthen them. 
 
Mechanically, cortical grafts are superior in comparison to cancellous grafts, but cortical 
grafts are poorer in providing biological support to bone growth, since they have less 
available cellular elements, growth factor, and their bulk structure prevents or slows 
vascularization. Cortical bone grafts can provide structural support and osteoconduction 
(Hoshijima et al. 1997). Nevertheless, they must be protected from full weight bearing by 
internal fixation, because fatigue fractures are common in a cortical strut graft that lacks 
vascularity. Resorption by osteoclasts is slow, as are revascularization and replacement with 
new bone laid by osteoblasts. A cortical autograft may never be completely resorbed, but 
usually remains as a mixture of graft bone and new bone, depending on the size of the graft. 
 
Autogenous cancellous bone represents the gold standard for clinical treatment in promoting 
the healing of bone defects and nonunions in human and veterinary medicine (Lane et al. 
1999, Guerrero et al. 2011). There are, however, a few major disadvantages in autogenous 
bone grafting. Bone harvesting is traumatic and prolongs the operating time (Bucholz et al. 
1989, Younger and Chapman 1989), causes pain and donor site morbidity (Chapman et al. 
1997, Bauer et al. 2000, Keating and McQueen 2001), and may thus result in complications. 
Also, the amount of graft bone available is limited (Keating and McQueen 2001). 
 
2.6.2. Allografts 
 
An allograft is a bone graft taken from another individual of the same species. A variety of 
allografts are available. The most common bone allografts in human bone banks are femoral 
heads obtained from primary hip arthroplasties. Allografts have weak osteoinductive and high 
osteoconductive properties (Moore et al. 2001, Giannoudis et al. 2005). Rinsing of 
morselized allografts improves their osteopromotive properties (van der Donk et al. 2003). 
The biomechanical properties of allografts depend on processing. Large structural allografts 
are able to give mechanical support (Enneking and Campanacci 2001), but they are prone to 
nonunion (Enneking and Campanacci 2001) and late stress fractures (Mankin et al. 1996). 
Particulate allogeneic cancellous bone grafts are used in promoting bone healing fractures, 
nonunions, and arthrodesis, and as filler for bone defects and for filling deficits adjacent to a 
revision stem (Gie et al. 1993, van der Donk et al. 2003, Baas 2008).  
 
Allografts are used as fresh-frozen or freeze-dried, which affects the graft-evoked immune 
responses (Stevenson and Horowitz 1992, Ryan et al. 2005, Diefenbeck et al. 2007). An 
immune response may lead to the complications of graft rejection, nonunion, and resorption 
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of the graft. Graft rejection is responsible for decreased vascularization and mineralization of 
allogeneic bone, as the graft becomes encased by fibrovascular repair tissue, chronic 
inflammatory cells, histiocytes and foreign body giant cells (Enneking and Campanacci 2001, 
Huber et al. 2009). In addition, aggressive resorption of graft bone by osteoclasts crossing the 
peripheral cement line and resorbing the interstitial lamellae has been described (Enneking 
and Campanacci 2001). 
 
Allogeneic bone grafting has disadvantages, such as limitation in availability, and the use of 
fresh-frozen allografts in particular includes an inherent risk of disease transmission 
(Simonds et al. 1992, Tomford 1995, Conrad et al. 1995). The processing of allograft bone 
can significantly weaken its biological and mechanical properties, although, it lessens the 
possibility of immunological responses (Boyce et al. 1999, Reikerås et al. 2011). 
Immunological responses may retard new bone growth and graft incorporation (Ehrler and 
Vaccaro 2000).  In the process of freeze-drying, allografts are washed in an antibiotic twice, 
then frozen at -70 oC and up to 5% of water is removed (Giannoudis et al. 2005). The freeze-
drying kills cells and affects the mechanical properties of graft material in a manner that 
freeze-dried allograft elicits a less immunogenic response but has inferior osteoinductive and 
mechanical properties and strength compared with fresh-frozen allografts. Freeze-dried bone 
can be further sterilized by ethylene oxide or gamma irradiation, which may further diminish 
the osteoinductive and mechanical properties (Giannoudis et al. 2005). 
 
In routine clinical practice, morselized impacted bone allografts are commonly used to 
reconstruct the bone bed in revision arthroplasties. Based on experimental models, load 
bearing increases the remodeling of impacted morselized allografts (Wang et al. 2000, Tägil 
2000, van der Donk et al. 2002). Bone morphogenic protein-7 (OP-1) stimulates bone 
formation and bone allograft remodeling in the peri-implant space (Jensen et al. 2002, 
Søballe et al. 2004), but the clinical proof of this action is still lacking. One potential option is 
to induce osteogenicity in the peri-implant allogeneic graft by introducing mesenchymal stem 
cells into the graft (Korda et al. 2008). 
 
2.6.3. DBM 
 
Demineralized bone matrix (DBM) is obtained by the acid abstraction of cortical bone (Urist 
1965). DBM is commercially available in many different forms and combinations. It is used 
as a bone graft extender rather than as a bone graft substitute (Khan et al. 2000, Sassard et al. 
2000). The demineralization process of bone matrix leaves behind bone osteoinductive 
growth factors, type I collagen, and noncollagenous proteins. Demineralized bone matrix, as 
a source of growth factors, is capable of inducing the formation of ectopic bone (Innes and 
Myint 2010, Wildermann et al. 2007).  
 
DBM preparations are generally well tolerated by the host, since antigenic determinants have 
been significantly modified. Demineralized bone matrix has been shown to improve the 
mechanical fixation of an implant, improve implant osseointegration, increase new bone 
formation, and decrease fibrous tissue formation in the vicinity of an implant surface in a 
dose-dependent way after packing with an allograft void filler around the implant in canine 
metaphyseal bone (Baas et al. 2006). Several clinical studies have proven the efficacy of 
demineralized bone matrix (Kuhls et al. 2001, Peterson et al. 2004, Bender et al. 2005), but in 
some studies no positive effect has been found (Cook et al. 2002, Becker et al. 1995).  
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The most important feature of demineralized bone matrix seems to be the wide spectrum of 
natural growth factors promoting the healing of mesenchymal tissues (Bormann et al. 2010), 
but there appear to be differences between commercial DBM products depending on the 
manufacturing process and source of bone matrix. It is difficult to determine the metabolic 
activity of the product after the demineralization process. The use of demineralized bone 
matrix has some disadvantages. The osteopromotive effect of the use of DBM has been 
described as being only mild. A risk of foreign body reactions may be included in the use of 
allogeneic and xenogeneic products.  
 
2.6.4. Calcium phosphate ceramics (HA and β-TPC) 
 
There is an increasing trend for the clinical use of synthetic bone graft substitutes. An ideal 
graft substitute should be osteoconductive, osteoinductive, biocompatible, bioresorbable, 
show minimal fibrotic reaction on maximal bone bonding, undergo remodeling, support new 
bone formation, and have adequate mechanical properties for its intended purpose and a 
modulus of elasticity similar to bone (Moore et al. 2001, Giannoudis et al. 2005). van der 
Stok et al. (2011) have recently reviewed the currently available graft substitutes. At present, 
the most common synthetic graft substitutes are calcium phosphate ceramics and calcium 
sulfates. The next-generation composite grafts, which are combinations of synthetic 
osteoconductive matrix and biological elements (osteogenic cells and growth factors), are 
also expected to have osteoinductive and osteogenic properties (Giannoudis et al. 2005). The 
optimal delivery system for recombinant growth factors, such as rhBMP-2, has not been 
resolved (Aro et al. 2011).  
 
The most widely used calcium phosphate ceramics are β-tricalcium phosphate (β-TCP, 
Ca3(PO4)2) and hydroxyapatite (HA, Ca10(PO4)6(OH)2). β-Tricalcium phosphate and 
hydroxyapatite are formed in the sintering of calcium ceramics, depending on the final firing 
conditions. Both phases are often present in the same final product. Wide variation exists in 
the physicochemical properties of these two synthetic calcium phosphates. β-Tricalcium 
phosphate is characterized by a high dissolution rate, which accelerates material resorbability. 
In contrast, hydroxyapatite has high chemical stability, causing restricted dissolution in vivo 
(O’Niell et al. 2007, da Silva et al. 2007).  
 
Dense synthetic hydroxyapatite has shown a tendency for fibrous encapsulation. Current 
calcium phosphate products are porous (Hing et al. 2004, 2005). As a result of mechanical 
interlock due to tissue penetration, these porous structures produce less fibrous encapsulation 
around the implants, and open porous structures promote the complete infiltration of bone 
tissue, bone marrow, and blood vessels similar to the incorporation of autogenous and 
allogeneic bone grafts (Ling et al. 1993). The dissolution rate of porous hydroxyapatite is also 
faster and may increase osteoinductivity (Yuan et al. 1999). Interconnectivity is essential 
because constrictions between pores and dead-end pockets limit vascular support and fluid 
circulation. Increased microporosity brought by porous hydroxyapatite in composite grafts is 
essential for osseointegration and elicits rapid neovascularization of the graft (Silva et al. 
2005). It seems that high interconnectivity of pores and a pore size (180–230 µm) similar to 
cancellous bone provides the highest level of osseointegration (Liu et al. 2000) 
 
Interestingly, too rapid dissolution of ultraporous β-tricalcium phosphate scaffold has been 
reported, provoking an inflammatory response that impairs new bone apposition followed by 
resorption of new bone (Hing et al. 2007). During the rapid chemical dissolution, Ca and PO4 
ions are released, which has a detrimental influence on the local pH (Klein et al. 1984). A 
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calcium concentration over 10 mM is cytotoxic (Maeno et al. 2005). However, a calcium 
concentration from 2 to 8 mM is known to be suitable for osteoblast proliferation, 
differentiation and extracellular matrix mineralization.  
 
2.6.5. Bioactive glasses 
 
Bioactive glasses are a family of biologically active, silica-based, synthetic biomaterials with 
desirable osteoconductive and osteopromotive properties for bone regeneration (Hench et al. 
1971, Hench and West 1996, Ducheyne and Qiu 1999, Hench and Polak 2002). In bioactive 
glasses, silica (SiO2) is the network former and alkali metals (sodium and potassium) or 
alkaline earth metals (calcium and magnesium) are the network modifiers. The biological 
properties of the glasses are composition-dependent (Ogino et al. 1980). Consequently, the 
rate of bone formation at a bioactive glass implant interface can be altered by changing the 
glass composition (Brink et al. 1997, Karlsson and Rönnlöf 1998).  
 
Calcium, phosphorus, and silicon play the main role in the bioactivity of glass. Silicon takes 
part in the metabolic processes during the formation and calcification of bone tissue. 
Orthosilicate acid, Si(OH)4, has been shown to stimulate osteoblastic differentiation and the 
formation of type I collagen in human osteoblasts (Reffitt et al. 2003). On the other hand, 
aluminum (Lindfors and Aho 2003) is known to decrease bioactivity, whereas strontium 
(Gentleman et al. 2010) and magnesium (Ahmed et al. 2010) increase the bioactivity of glass. 
Numerous studies have been performed on different ion-doped bioactive glasses to determine 
the effect on bioactivity, which depends on the concentration of dissolved metal ions in the 
physiological environment as a consequence of ion dissolution and on the release kinetics of 
the glass (Hoppe et al. 2011).  
 
The solubility and bioactivity increase as the concentration of the network former (Si) 
decreases in the glass. Bioglass 45S5® developed by Hench, containing 45 wt% silica, has 
been found to have the highest stimulatory effect on bone cell function (Schepers et al. 1991, 
Ogino et al. 1980, Klein et al. 1983, El-Ghannam et al. 1999,  Garcia et al. 1998, Oonishi et 
al. 1997). Bioactive glasses containing 45–52 wt% silica bond fastest to bone, and these 
glasses are also able to form a chemical bond with soft tissues. More slowly reacting 
bioactive glasses containing 55–60 wt% silica show long-lasting bioactivity, but do not bind 
to soft tissues (Hench and West 1996). The osteogenic effect of bioactive glass is mediated 
by the surface characteristics and the ion dissolution (Radin et al. 2005). Bioactive glasses 
have been found to have gene-activating properties (Xynos et al. 2001, Jell et al. 2008) and a 
stimulatory effect on the secretion of angiogenic growth factors and angiogenesis (Day 
2005). They also have antibacterial properties that are explained by the high pH and ion 
release (Gubler et al. 2008, Zhang et al. 2010). 
 
Bioactive glass has an amorphous structure that facilitates ion release into physiological 
solutions and subsequent bioactivity reactions (Andersson et al. 1991). Bioactive glass is an 
osteopromotive surface-active material that forms an apatite film on top of a SiO2-rich layer 
when brought in contact with body fluids (Andersson et al. 1990, Hench and West 1996). The 
body recognizes this carbonated hydroxyapatite surface to be bone-like and will deposit bone 
on such a surface (Hench 1998). The presence of serum proteins controls the growth of the 
amorphous calcium phosphate layer and modifies crystallization (Mei et al. 1995, Effah 
Kaufmann et al. 2000, Buchanan et al. 2010). On the other hand, the crystallization of 
bioactive glass has been shown to decrease protein absorption onto the material surface 
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compared with amorphous bioactive glass (El-Ghannam et al. 2001, Buchanan and El-
Ghannam 2010).  
 
Bioactive glass promotes three times more bone growth than hydroxyapatite, when implanted 
in bone (Fujishiro et al. 1997, Tan et al. 2010). Bioactive glasses are nontoxic (Wilson et al. 
1981, Floppiano et al. 2007) and degraded by dissolution and osteoclastic cleavage (Schepers 
et al. 1991, Radin et al. 2000). When bioactive glass is exposed to body fluid in vivo or SBF 
in vitro, the dissolution of glass, the leaching of ions from glass, and the precipitation of 
calcium phosphate occurs. The speed of reactions reflects the bioactivity of the glass. Hench 
and coworkers have described 11 different stages (Fig. 2.1) in bone bonding of bioactive 
glasses (Hench and Paschall 1974, Hench and West 1996).  
 
Key steps in the activity of bioactive glass are attributed to calcium phosphate formation, 
surface hydroxylation, and fibronectin absorption. Surface hydroxyl groups play an important 
role in bioactivity (Toworfe et al. 2009). Silica gel in the bioactive glass surface provides a 
large number of silanol (Si-OH) terminations, which flex to match the crystals of 
hydroxyapatite and act as nucleation sites (Karlsson et al. 1989, Kokubo 1991, Li and Zhang 
1990, Li et al. 1994). Ca2+ is deposited on the surface and induces phosphate precipitation. 
Fibronectin attaches to the calcium phosphate surface and plays a crucial role in osteogenic 
cell attachment, proliferation and differentiation (El-Ghannam et al. 1999, Garcia et al. 1998, 
Kotobuki et al. 2005).  Enhancement of bioactive glass activity has been shown to be possible 
by alkaline phosphatase coating directly in hydroxyl groups or covalently anchored to the 
silanized surface (Verné et al. 2010). 
 
Figure 2.1. Chemical and cellular reaction steps leading to bone formation on the surface of 
bioactive glass implanted into the body. Modified from Hench and West (1996). 
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As with any glass, the amorphous structure of bioactive glass impairs the mechanical strength 
of the material and its fracture toughness. The brittleness of bioactive glass restricts its use for 
load-bearing applications. Bioactive glass has been successfully used as a bone substitute 
material for nonload-bearing applications in preclinical models (Schepers et al. 1993, 
Johnson et al. 1997, Schepers & Ducheyne 1997, Virolainen et al. 1997, Furusawa et al. 
1998, Wheeler et al. 1997, Oonishi et al. 2000, Vogel et al. 2001, Lindfors & Aho 2003) in 
orthopedic and dental surgery (Shapoff et al. 1997, Tadjoedin et al. 2000, Ilharreborde et al. 
2008, Lindfors et al. 2010a,b).  
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2.7. ANIMAL MODELS FOR BONE IMPLANT STUDIES 
 
Implant materials go through the exhaustive testing of physicochemical properties while they 
are developed. Surface reactions can be tested in fluid simulating body fluids (SBF). The 
mechanics of implant design can be simulated in finite element models. Cell culture 
techniques are also very important to determine how cells behave on the surface of the 
material. In vitro cell culture testing gives information regarding cytotocity, genocity, cell 
proliferation and differentiation. It is more easily standardized and quantifiable than in vivo 
testing. Results from in vitro testing can be difficult to extrapolate to the in vivo situation. 
Animal experiments are essential for understanding of the bone-implant interface at the tissue 
level. They are needed for evaluating biocompatibility, the tissue response and the 
mechanical functioning of an orthopedic implant.  
 
An optimal animal model shows physiological and pathological similarities with humans and 
provides a possibility to observe numerous subjects over a relative short time frame in 
standardized testing conditions. Bone graft substitutes are tested first in ectopic bone 
formation models to evaluate osteoinductive properties in heterotopic (subcutaneous, muscle, 
or intraperitoneal) sites, where bone does not normally exist. Explanted samples are 
examined radiographically and histologically to identify the existence and quality of bone 
formation 3 to 24 weeks after implantation. Subcutaneous testing is also the standard site for 
screening, biocompatibility and toxicity testing of all new potential clinical biomaterials.  
 
In the development of a medical implant, inexpensive unloaded small animal models such as 
the rat (Kratzel et al. 2008), guinea pig (Witte et al. 2006) or rabbit (Shirai et al. 2011, 
Hermida et al. 2010) are usually first used to study tissue reactions. The bone turnover of 
rabbit is rapid (Sennerby et al. 1993) and the ratio of the bone healing time between rabbits 
and humans has been approximated at 1:3 (Roberts 1988, Castaneda et al. 2006). In addition, 
rabbit long bones have a different histological structure from humans (Wang et al. 1998, 
Martiniakova et al. 2005). This makes it difficult to extrapolate the results from rat or rabbit 
studies to the likely human response (Akiyama et al. 2011). For example, Aspenberg et al. 
(1992) reported that demineralized bone matrix induced extraskeletal bone formation in 
rodents, but effects of the same material were uncertain or negative in dogs and primates.  
 
Therefore, the preclinical testing of biomaterials must be performed using larger animals such 
as sheep (Viguier et al. 2011,  Dias et al. 2010), goats (Biemond  et al. 2011), dogs (Daugaard 
et al. 2011) or pigs (Ponader et al. 2010, Thorwarth et al. 2005), which have a rate of bone 
healing and bone turnover similar to humans (Hemmerle et al. 1997, Chavasieux et al. 1991, 
Kaymakci and Wark 1994, Raddar et al. 1994, den Boer  et al. 1999, Blokhuis et al. 2000, Liu 
et al. 2000). They also show only minor differences in bone composition compared with 
humans (Pearce et al. 2007). Bone regeneration rates in a study by Laiblin and Jaeschke 
(1979) were 1.5–2.0 mm/day in the dog, 1.2–1.5 mm/day in the pin pig, and 1.0–1.5 mm/day 
in humans. In a quantitative histological study by Kimmel and Jee (1982), the remodeling 
rate in the dog was 2–3 times faster than in humans.  
 
Guidelines for sizing the implant for in vivo testing are provided by International Standard 
ISO 10993-6, 2007. The dimensions of implants are chosen according to the size of the 
animal and the bone used to avoid iatrogenic fractures. Loaded animal models are essential 
for evaluating the mechanical functioning of an orthopedic implant, since without load the 
resorption of bone will increase (Vico et al. 1987). Thus, controlled physiological loading has 
been shown to improve osseointegration (Willie et al. 2010). 
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Implants have been tested in different regions of bone: in cortical (diaphyseal) and cancellous 
(metaphyseal) bone areas. It is well known that different implantation areas have different 
metabolic activities and cellular recruitment sources, leading to differences in effects on the 
bone growth rate into the implant and implant incorporation (Carter 1984, Bertram and 
Swartz 1991, Kimmel and Jee 1982, Pearce et al. 2008). Therefore, to exclude the effect of 
implantation site, bone chamber studies have become more popular (Geris et al. 2004, Moalli 
et al. 2000, Tagil and Aspenberg 1999). It is simpler to compare different implants in the 
similar mechanical environment of a bone chamber for all of the materials in the test. The 
mechanical environment in a bone chamber can be simulated by adding a moving plunger in 
the chamber (Søballe 1992a,b, Søballe 1993b). In bone chamber studies, follow up times of 
three to six weeks are expected to present an adequate window in which healing would be at 
a stage where differences in new bone formation, bone graft resorption and implant 
incorporation between the test groups would be identifiable, if present (Baas 2008). The 
differences between groups may level out at a much later time point. The transcortical site 
has also been extensively used by various investigators (Raddar et al. 1994, Itälä et al. 
2003a). The transcortical model allows for the quantification of morphological observations. 
Although it is not functionally loaded, it has been shown to be effective in the evaluation of 
biomechanical parameters (interfacial strength). 
 
The mechanical performance of different tissue interfaces in the hip implant might best be 
tested using larger animal models. Total hip and hemiarthroplasty models are used with the 
dog (Turner et al. 1986, Bobyn et al. 1987, Cook et al. 1992a, DeYoung et al. 1992, Eckardt 
et al. 2003, Marcellin-Little et al. 2010), and increasingly with the sheep (Phillips et al. 1987, 
Moroni et al. 1999, Dorian et al. 2003, Korda et al. 2008, Coathup et al. 2008). In these 
models it is possible to test different implant designs and the effect of loading. A lot of work 
in the past has been performed with canine models because of the reasonably easy 
availability, activity level, training, longevity, reasonably large bone size, and the large 
information base concerning functional anatomy and loading (Palierne et al. 2006). The 
anatomic size of sheep hips is close to that in humans, and the increasing knowledge of 
anatomy and physiology supports experimental sheep hip implantation (El-Warrak et al. 
2004). Korda et al. (2008) have emphasized that the proximal sheep femur is characterized by 
tubular geometry of the medullary canal and the presence of yellow adipocytic bone marrow, 
which simulates the conditions of patients undergoing revision hip arthroplasties. One of the 
limiting factors is that sheep, as ruminants, are relatively difficult animals to work with 
experimentally. One concern compared with humans is that sheep and canines are quadruped 
models, which makes the sparing of an operated limb from loading possible without 
significant signs.  
 
Bone graft materials are evaluated for osteoproductive properties in orthotopic sites after 
testing in an ectopic site. Typical models for this type of testing are a critical-sized diaphyseal 
defect or a fracture healing model. A critical size defect, as defined by Schmitz and Hollinger 
(1986), is the smallest defect not to heal spontaneously over a given period of time. The size 
of a critical size defect is approximately twice the diameter of bone, but each model has a 
specific critical size defect, the size of which can vary with age, weight, and strain in a given 
species.  
 
Five types of bone defect models are mainly utilized: a long bone or segmental defect, 
calvarian defect, partial cortical defect (cortical window, transcortical drill hole, or wedge 
defect), cancellous bone defect (drill holes), and gap-healing around an implant. For 
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segmental defect models, rabbits (Kuzyk et al. 2010), dogs (Lindsey et al. 2006), sheep 
(Chang et al. 2009, Gao et al. 1995), and goats (Nair et al. 2010, Bullens et al. 2010) are most 
commonly utilized to evaluate the structural properties of the material. Dogs and sheep 
require the use of internal or external fixation in bone defect models. Rats (Ivanovski et al. 
2011, Leu et al. 2009) and rabbits (Peltola et al. 2001) are used in calvarial bone defect model 
to test particulate bone graft substitutes implanted between the dura and periosteum without a 
need for any additional stabilizer. The rat calvaria defect has a poor blood supply and little 
bone marrow, creating an unfavorable environment for bone formation, and is used as an 
orthotopic site for testing the osteoconductivity and osseointegration of the implant material 
as well as material degradation.  
 
Gap healing models are useful to test bone grafting and bone graft substitutes around 
implants (Kienapfel et al. 1992, Shih et al. 2005, Kold et al. 2005). A controlled defect (gap) 
is created at the bone-implant interface and filled with graft material. A three millimeter gap 
is commonly utilized, but gaps of over half a millimeter have already been found to inhibit 
implant gap healing and reduce the quality of the bone at the interface (Harris et al. 1983, 
Sandborn et al. 1989, Dalton et al. 1995, Hofmann et al. 1997). The gap-healing model can be 
loaded or non-loaded (Søballe et al. 1992b).  
 
Radiographic evaluation at regular intervals during the postoperative period provides a 
noninvasive method for examining the graft site. The amount, structure and density of new 
bone can be measured by the methods of plain radiography, dual energy X-ray absortiometry 
(DXA), quantitative computed tomography (QCT), peripheral quantitative computed 
tomography (pQCT) and microquantitative computed tomography (µQCT). Biomechanical 
testing is performed to evaluate the mechanical incorporation of an implant or bone graft post 
mortem. Tensile, compressive, and torsional testing is commonly used to obtain a load-
deformation curve and biomechanical parameters (ultimate load, stiffness, displacement to 
failure, and ultimate strength), which are calculated from the curve. Histological analysis is a 
powerful method for examining bone healing. Bone union, new bone formation, the 
resorption of a graft, cortical remodeling, and the implant failure mode can be evaluated. 
Calculation of the percentage of bone filling, fractions of different tissues present and bone-
implant contact can be accurately performed by computerized image analysis 
histomorphometry (Bensen et al. 2000). 
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3. AIMS OF THE STUDY 
 
This study started as the preclinical arm for TEKES (the Finnish Funding Agency for 
Technology and Innovation) supported multi-institutional projects (contracts 40317/00 and 
40229/01) on clinical applications of novel bioactive glass formulations of the Na2O-K2O-
MgO-CaO-B2O3-P2O5-SiO2 system. The clinical goal was to develop synthetic bone graft 
substitutes and bioactive coating techniques for clinical needs in revision hip arthroplasties. 
 
The study evaluated the use of bioactive glasses as sintered porous inlays of implant surfaces 
and as laser-deposited coating materials in the enhancement of osseointegration of cementless 
bone implants. Bioactive glass granules were also studied as extenders of autogenous or 
allogeneic bone grafting in the filling of the peri-implant space. 
 
The following questions were addressed: 
 
1. Do porous inlays made of bioactive glass microspheres or granules improve the 
osseointegration of intramedullary grit-blasted titanium alloy stems under unloaded 
conditions in the sheep proximal femur? 
 
2. Do porous inlays made of bioactive glass microspheres improve the osseointegration 
of cortical macrotextured titanium and CoCr alloy implants under unloaded conditions 
in the sheep tibia? 
 
3. Does the supplementation of periprosthetic autogenous bone grafting with bioactive 
glass granules improve the osseointegration of a cementless intercalary grit-blasted 
titanium alloy prosthesis in a segmental bone replacement model of the canine femur? 
 
4. Does the concurrent use of bioactive glasses as laser-deposited coating materials and 
in the supplementation of periprosthetic allogeneic bone grafting promote the  
osseointegration of a cementless intercalary grit-blasted titanium alloy prosthesis in a 
segmental bone replacement model of the canine femur? 
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4. MATERIALS AND METHODS 
 
4.1. BIOMATERIALS 
 
4.1.1. Bioactive glass compositions 
 
The compositions of bioactive and biocompatible glasses used in studies I–IV are presented 
in Table 4.1. The glasses were manufactured by Vivoxid Ltd, Turku, Finland. 
 
Table 4.1. Compositions (expressed as weight-percentage) of four bioactive glasses and one 
biocompatible glass (glass with low bioactivity, S59.7P2.5) used in the studies of this thesis. 
 
Glass SiO2 Na2O CaO K2O MgO P2O5 B2O3 
13-93 53 6 20 12 5 4 -- 
1-98 53 6 22 11 5 2 1 
3-98 55 4 22 9 5 4 1 
S53P4 53 23 20   4  
S59.7P2.5 59.7 25.5 11   2.5 1.3 
 
4.1.2. Porous inlay of bioactive glass microspheres 
 
Bioactive glass (BG) microspheres of three different compositions (13-93, 1-98, 3-98) were 
manufactured using a plasma spraying method (Pitkänen et al. 1995). In order to obtain 
bioactive glass test bodies to be used as inlays with a controlled porosity, a narrow fraction (  
250–300 m) of such microspheres of three different compositions (13-93, 1-98, 3-98) for the 
primary stem simulation (I) and a sieved fraction (500–1000 m in size) of glass 1-98 
granules for the revision stem simulation (I) were sintered in a graphite mold at 700–730 C 
to the form of porous bodies with dimensions corresponding to those of the grooves, slots, or 
holes in the titanium implants. 
 
For study II, two glass compositions (highly bioactive glass 13-93 and biocompatible glass 
with low bioactivity, S59.7P2.5) were used for sintered porous inlays made of bioactive 
active microspheres alone (BG 100%), or a mixture of bioactive microspheres and 
biocompatible glass (BC) granules, where the proportion of bioactive glass was 35%, 50%, or 
65%. 
 
4.1.3. Molded and laser-deposited bioactive glass coating 
 
For layered glass coated implants (II), two or three layers of glass with increasing bioactivity 
towards the top were molded on the surface of a smooth cobalt chromium alloy (CoCr) 
implant. Inert enamel glass was in contact with the cobalt chromium alloy implant, and the 
next layer was biocompatible glass S59.7P2.5. The third layer in implants with three glass 
layers was glass 13-93. 
 
Coating of the stem grooves with bioactive glass 1-98 was performed in three layers using a 
CO2 laser (IV). The focused CO2 beam was used to locally melt bioactive glass 1-98 powder 
(< 45 µm fraction) and attach it to the titanium alloy substrate, creating numerous micro-sized 
(Ø  60 µm) bioactive glass ‘drops’ (Moritz et al. 2004a). 
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4.1.4. Bioactive glass granules as a bone graft extender 
 
A sieved fraction (1000–3000 µm) of bioactive glass 1-98 granules in the revision stem 
simulation (I) and  500–800 μm granules of glass S53P4 (III and IV) was used as a bone 
graft extender. 
 
4.1.5. Metal alloy implants 
 
Implants for all four studies we were made by Valdemar Link GmbH, Hamburg, Germany. 
 
For the primary stem simulation (I), a total of 18 cylinder-shaped titanium alloy (Ti6Al4V) 
implants were manufactured in standard dimensions (diameter 10 mm, length 50 mm) (Fig. 
4.1.A). The proximal 20 mm of the implants were roughened by a grit blasting method used 
for clinical orthopedic implants (Link GmbH, Hamburg, Germany). Three surface slots of 
standard dimensions (diameter 5 mm, depth 6 mm) were made in the grit-blasted area. The 
slots of each implant were filled by porous bioactive glass inlays. Similar non-slotted solid 
stems were used as controls. 
 
For revision stem simulation (I), a total of 16 cylinder-shaped titanium alloy (Ti6Al4V) 
implants were manufactured in standard dimensions (diameter 10 mm, length of 70 mm) 
(Fig. 4.1B). The grit blasting was extended to cover the whole length of the stem with seven 
perforating holes (diameter 6 mm). The bioactive glass bodies were manually press-fitted into 
the holes. Fully grit-blasted, non-perforated solid stems were used as controls. 
 
 
 
Figure 4.1. To the left, a cylinder-shaped titanium alloy implant (50 mm in length) with three slots 
for bioactive glass inlays and a solid control implant applied in the simulation of uncemented 
primary stems in study I (A). The fully grit-blasted revision stems (70 mm in length) with seven 
perforating holes filled by bioactive glass inlays and a solid control implant in study I (B). The 
schematic drawings show the dimensions of the slots of the primary stems (upper) and the holes of 
the revision stems (lower).  To the right, AP radiographs of sheep proximal femurs with a primary 
stem with bioactive glass inlays (A) and a revision stem with bioactive glass inlays and peri-implant 
space filling with a mixture of autogenous bone graft and bioactive glass  granules (B) 12 and 25 
weeks after implantation, respectively. 
 
For study II, a total of 160 disc-shaped (diameter 14 mm) cortical bone implants made of 
titanium alloy (Ti6Al4V) or cobalt chromium alloy were manufactured (Waldemar Link 
GmbH, Hamburg, Germany) (Fig. 4.2). A total of 62 implants had two parallel trapezoidal 
grooves (depth 3.0 mm, base width 3.0 mm, surface opening 2.0 mm), which were filled with 
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the previously described sintered porous inlays. The glass inlays were manually press-fitted 
into the grooves of the titanium alloy implants. In the cobalt chromium alloy implants, the 
glass inlays were fixed within the grooves with enamel. A total of 32 corresponding disc-
shaped smooth cobalt chromium alloy implants were manufactured and their surface was 
coated with two or three layers of bioactive glass using an enameling technique with 
increasing glass bioactivity towards the top. In addition, a total of 66 control implants in 
standard dimensions were used, including titanium alloy implants with unfilled grooves (Fig. 
4.2A) and a smooth (Fig. 4.2B) or microroughened surface manufactured using a clinical 
grit-blasting method (Waldemar Link GmbH, Hamburg, Germany), and cobalt chromium 
alloy implants with unfilled grooves or with a smooth surface. 
 
 
 
Figure 4.2. Titanium implants with a grooved (A) and smooth (B) surface in study II. To the left (A), 
the upper surface of implants with a central hole for the fixation screw and two slots for a torque 
tester key are seen. Immediately to the right (A, B), the same implants lie inverted, showing a 
grooved (A) and smooth (B) bone-facing surface. Radiograph (C) showing three grooved titanium 
alloy implants fixed by 3.5 mm cortical screws to the leveled out medial surface of the sheep tibia. 
 
Based on CT imaging of a pair of representative canine femurs, a total of 32 custom-designed 
titanium alloy (TiAl6V4) segmental intercalary femoral prostheses were manufactured 
(Waldemar Link GmbH, Hamburg, Germany) for studies III (Fig. 4.3A) and IV (Fig. 4.3C). 
The prosthesis used in study III was modified from the original canine model (Virolainen et 
al. 2005) and further improved for study IV. In study III, the outer diameter of the 20-mm-
long proximal and distal intramedullary stems of the intercalary femoral prostheses was 6 or 
7 mm and 7 or 8 mm, respectively. In study IV, the stem diameter was 8.5 mm and length 30 
mm. Stems were joined together by a 16-mm-long interconnecting body part with a locking 
mechanism. The outer diameter of the body part (16 mm) corresponded to the average 
diameter of the canine femurs. The stems were longitudinally grooved (to a depth of 1.0 mm, 
with an opening angle of 60º) and microroughened by a grit-blasting method used for clinical 
orthopedic implants. For additional rotational stability, the interconnecting body part had a 
proximal and distal side-plate with two holes each for interlocking screws in study III. The 
central interlocking screw was a monocortical 2.7 mm mechanical screw locked to the stem, 
and the peripheral interlocking screw was a 2.7 mm bicortical bone screw. In study IV, each 
stem had two 3.6-mm-wide penetrating holes for 3.5 mm bicortical interlocking screws for 
additional rotational stability. The length of the holes was 5.1 mm to allow initial subsidence 
after the operation. 
Study III    Study IV 
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Figure 4.3. Custom-designed titanium alloy intercalary prosthesis of the canine femur with side-
plates and interlocking screws in study III (A) or with interlocking screws only in study IV (C) for 
interlocking of the proximal and distal stems. Grit-blasted stems had longitudinal grooves and one of 
the stems (in this case distal in C) was coated with bioactive glass (whitish color).  (B) An anterior-
posterior radiograph of a femur 12 weeks (B) and three months (D) after the implantation. The 
radiograph indicates pQCT scan levels of interest (IV) and the three levels of histological sections (III 
and IV). 
 
After bioactive glass coating, the implants were washed in an ultrasound cleaner with acetone 
and ethanol for 5 minutes each. All implants were sterilized in an autoclave (121 ºC, 16 min, 
1 bar). 
 
4.2. ANIMAL MODELS 
 
A total of 41 adult 2- to 4-year-old ewes (Finnish landrace, A.A. Koivisto, Viljakkala, 
Finland) 40–70 kg in weight (I and II), and 16 adult mongrel male dogs (Harlan, Zeist, the 
Netherlands) 15.4–23.1 kg in weight (III and IV) were used. Before surgery, the femurs were 
X-rayed for any structural abnormality and to confirm the closure of growth plates as a sign 
of skeletal maturity (III and IV).  
 
The surgical protocols were approved by the Institutional Animal Care Committee of the 
Faculty of Veterinary Medicine, the University of Helsinki (I–IV) and the State Provincial 
Office of Southern Finland (II–IV). 
 
4.3. EXPERIMENTAL PROCEDURES 
 
Experimental settings are presented in Table 4.2. 
 
 
 
 
Table 4.2. Experimental settings.  
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 Study I Study II Study III Study IV 
Purpose of  study Porous BG inlays 
in the promotion 
of implant 
incorporation 
Different porous 
BG inlays and 
surface textures 
in the promotion 
of implant 
incorporation 
BG granules 
mixed with 
autograft in the 
promotion of 
implant healing 
Laser-deposited 
BG coating and 
BG granules 
mixed with 
allograft in the 
promotion of 
implant healing 
Experimental 
model 
Unloaded sheep 
model, primary 
and revision stem 
simulation 
Unloaded sheep 
model + cadaver 
bone study 
Loaded canine 
segmental 
prosthesis model 
with autograft 
Loaded canine 
segmental 
prosthesis model 
with allograft 
Implantation site Proximal femoral 
medullary canal 
Medial tibial 
cortex 
Femoral 
medullary canal 
after mid-
diaphyseal 
segment 
removal 
Femoral 
medullary canal 
after mid-
diaphyseal 
segment 
removal 
Animals 17 female sheep 24 female sheep 8 male dogs 8 male dogs 
Implant 34 grit-blasted Ti 
stem implants 
with or without 
slots in primary 
stems (n=9), or 
holes in revision 
stems (n=8) 
160 grooved, grit-
blasted and 
smooth Ti and 
CoCr disk 
implants 
16 grit-blasted Ti 
segmental 
intercalary 
prostheses with 
side plate and 
cortical screws 
16 grit-blasted Ti 
segmental 
intercalary 
prostheses with 
interlocking 
cortical screws 
Glass surface Porous inlays 
sintered from 
glasses 13-93, 1-
98, or 3-98 
microspheres slot 
(in primary 
stems) or 1-98 
granules  (in 
revision stems) 
Porous inlays 
sintered from 
glass 13-93 
micro-spheres 
and 
biocompatible 
glass granules.  
2- or 3-layer BG 
coating. 
 CO2 laser-fixed 
glass 1-98  
Peri-implant 
bone graft 
Autogenous bone  
(in revision stem 
simulation) 
 Autogenous 
bone   
Allogeneic bone 
chips, DBM, 
autogenous 
bone marrow 
aspirate 
Peri-implant 
bone graft 
extender 
1-98 granules  (in 
revision stem 
simulation) 
 S53P4 granules   S53P4 granules   
Follow-up 12 and 25 weeks 12 and 25 weeks 12 weeks 12 weeks 
 
BG = bioactive glass, Ti = titanium alloy, CoCr = cobalt chromium alloy 
4.3.1. Anesthesia and perioperative antibiotics 
The sheep were sedated by intramuscular injection of medetomidine 25 µg/kg (Domitor , 
Orion Pharma, Espoo, Finland). Anesthesia was induced with propofol 5 mg/kg (Recofol , 
Leiras, Helsinki, Finland) intravenously. After endotracheal intubation, general anesthesia 
was maintained with halothane (1–2%) (Trothane , ISC Chemicals, Bristol, UK) in study I 
and 1.5–2% isoflurane (Forene, Abbott Scandinavia AB, Solna, Sweden) in study II using 
assisted ventilation. A single dose of prophylactic antibiotic, enrofloxacin 5 mg/kg (Baytril, 
Bayer, Leverkusen, Germany) (I) and penicillin-G 40 mg/kg (Geepenil, Orion 
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Pharmaceuticals, Finland) (II) was administered intravenously at the time of endotracheal 
intubation. 
 
The dogs (III and IV) were sedated with a combination of medetomidine 20 μg/kg 
(Domitor®, Orion Pharma, Espoo, Finland) and butorphanol 0.1 mg/kg (Torbugesic®, Fort 
Dodge Animal Health, Fort Dodge, IA, USA) administrated intramuscularly. Anesthesia was 
induced with propofol 1 mg/kg (Recofol®, Leiras, Helsinki, Finland) intravenously. After 
endotracheal intubation, general anesthesia was maintained with 1.5–2% isoflurane (Forene, 
Abbott Scandinavia AB, Solna, Sweden) using assisted ventilation. A dose of prophylactic 
antibiotic, cefalotin 20 mg/kg (Keflin®, Eli Lilly and Company, Indianapolis, IN, USA), was 
administered intravenously at the time of endotracheal intubation, and a dose was repeatedly 
administered every two hours.  
4.3.2. Surgical procedures 
 
Standard sterile surgical techniques were followed. Operations were performed bilaterally in 
all animals. 
 
In the primary stem simulation (I), the medullary cavity of the proximal femur was opened at 
the piriformis fossa and the medullary canal was reamed by using a 10 mm cannulated hand 
drill. The stem was introduced into the canal (Fig. 4.1A) using a light hammer until at the 
pre-determined position. The implantation procedure was repeated identically on the 
contralateral femur.  
 
The bilateral retrieval of autogenous iliac bone graft in the revision stem simulation (I) and in 
study III or iliac medullary bone marrow aspiration in (IV) was performed first in each 
animal. For autogenous bone retrieval, the pelvic wing was exposed dorsally and 
predominantly cancellous bone graft was chiseled from the iliac bone and nibbled into small 
chips with a rongeur (III). For bone marrow aspiration, the dorsum of an ileal wing was 
punctured by a disposable 15G Illinois bone marrow aspiration needle, and 2 ml of bone 
marrow was aspirated to act as a component of the bone grafts (IV). 
 
In the revision stem simulation (I), the medullary canal of the proximal femur was opened at 
the piriformis fossa and reamed with a 10 mm cannulated drill. Fatty bone marrow was 
washed out by using pulsatile lavage (Stryker SurgiLav® Plus, Kalamazoo, MI, USA), and 
the prepared autogenous bone graft (Table 4.3.) was packed into the walls of the medullary 
canal by using a custom-made instrument (8 mm steel pipe with a plunger). Using the press-
fit technique, the revision stem was hammered into the medullary canal (Fig. 4.1B) until at 
the pre-determined level. The revision stems with bioactive glass inlays and the solid control 
stems were implanted in a randomized order into the right and left femurs of each animal. 
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Table 4.3. Compositions of composite grafts used in studies I, III, and IV. 
 
 Study I Study III Study IV 
Bioactive glass 
granules, size 
1-98,  
1000–3000 µm 
S53P4, 
500–800 µm 
S53P4, 
500–800 µm 
Bone graft Corticocancellous 
autogenous bone  
(chip size < 5 mm with 
a rongeur) from ileal 
wing  
 
Corticocancellous 
autogenous bone      
(chip size approx. 1 × 1 
× 2 mm with a rongeur) 
from ileal wing  
 
Freeze-dried canine 
allogeneic cancellous 
bone chips (size < 2.5 
mm) combined with 
demineralized bone 
matrix† plus 
autogenous bone 
marrow aspirate 
Ratio of synthetic 
ceramic bone 
substitute to bone 
graft 
1:1 1:1 1:1 
 
†Osteo-Allograft Fine Mix™, Veterinary Transplant Services Inc., Kent, WA, USA 
 
In study II the anteromedial surface of the proximal tibia was exposed and the periosteum 
was elevated. The cortical bone was prepared for implantation of three parallel cortical 
implants (Fig. 4.2C) using a drilling guide in order to ensure standardized and correct 
positioning. For each implant, a central hole was drilled through both cortices. The slightly 
curved surface of the cortical bone was smoothened using a custom designed slow-speed 
rotating instrument (diameter 14 mm) under saline irrigation. This was done to ensure an 
even contact between the implant surface and the bone. Two additional cortical bone holes 
(diameter 2.5 mm) positioned to face the implant grooves were drilled in designated 
locations. These holes were intended to facilitate direct angiogenesis and the migration of 
osteoprogenitor cells from the medullary canal into the site of new bone formation within the 
implant grooves. The implants were securely fixed to the designated position with a central 
3.5 mm bicortical screw and tightened using a torque wrench. Soft tissues were closed in 
layers. The implantation procedure was repeated identically on the contralateral tibia. The 
animals were operated in a sequence of eight animals in three groups and a randomized order 
was prepared for the bilateral placement of six different implants in each animal. 
 
In studies III and IV, the femoral shaft was exposed through a lateral intermuscular 
approach. Corresponding to the length of the body of the prosthesis, a 16-mm-long segment 
of the femoral shaft was resected just distally to the entry site of the femoral nutrition artery. 
Using non-powered reamers, the medullary canal was reamed by 1 mm increments to the 
final diameter of 6, 7, or 8 mm in the proximal and distal directions at a depth of 30 mm in 
study III, and to 8.5 mm and 40 mm, respectively, in study IV. Before implantation, the canal 
was pressure lavaged (Stryker SurgiLav Plus, Kalamazoo, MI, USA) (III). In a sequential 
order, the left and right femoral canals were packed with a 1:1 mixture of autogenous bone 
and bioactive glass (Table 4.3.) or with bone graft alone (III) or a 1:1 mixture of allogeneic 
bone and bioactive glass (Table 4.3.), or with allogeneic bone graft alone (IV), as 
recommended in the use of ceramic bone graft substitutes (Verdonschot et al. 2001). Before 
implantation, the graft mixture of allogeneic bone and bioactive glass was supplemented with 
bone marrow (2 ml) aspirated from the ileum in order to improve the adhesion of biomaterial 
particles (van Haaren et al. 2005). The graft mixtures were gradually introduced into the 
medullary canals and sequentially impacted by a blunt impactor. The depth of medullary 
filling was confirmed by means of gauge measurement. The total amount of graft was 
approximately 1.5 ml around each proximal and 3 ml around each distal stem (III and IV). 
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The grooves of the stems were filled with the graft mixtures and the tight-fitting implants 
were press-fitted into the medullary canals (Fig. 4.3B of study III, Fig. 4.3D of study IV). 
The side-plates (III) or stems (IV) were fixed with interlocking screws with the help of a 
guide jig (IV). The proximal and the distal stems of the prosthesis were joined together and 
locked with a screw. The surgical field was irrigated with saline. Fascia, subcutaneous tissue 
and skin were closed in layers. 
 
4.3.3. Postoperative pain medication  
 
After recovery from anesthesia, the animals received standard postoperative pain medication 
consisting of buprenorphine (Temgesic®, Reckitt & Colman, Hull, England), which was 
continued for three days in studies I and II, and buprenorphine 0.03 µg/kg continued with 
transdermal patches of fentanyl 50 µg/h (Durogesic®, Janssen-Cilag, Beerse, Belgium) for 
three days in studies III and IV. 
 
4.3.4. Harvesting of implant specimens 
 
Sheep were euthanized using a captive bolt pistol (I and II) 12 and 25 weeks after surgery 
and dogs by an intravenous injection of sodium pentobarbital (Mebunat , Orion Pharma, 
Espoo, Finland) after sedation (III and IV) 12 weeks after surgery. Following euthanasia of 
the animals, the bone specimens with the implants were harvested, cleared of all soft tissues, 
wrapped in saline soaked towels, and preserved in sealed plastic bags at –18 C for 24 hours 
and then at –70 C until analyzed. In study IV the specimens were preserved in sealed plastic 
bags in ice after harvesting until biomechanically tested within 24 hours, but otherwise the 
preservation of the specimens did not differ from studies I–III. 
4.3.5. Cadaver testing of cemented implants 
 
Simulating the implantation techniques of in vivo implants, eight smooth and eight grooved 
cobalt chromium alloy implants were cemented onto the anteromedial proximal surface of six 
cadaver sheep tibias (I). Since the fixation strength of cemented implants is at the maximum 
immediately after implantation and will eventually diminish with time in vivo, an ex vivo 
model was selected for testing of the torsional failure load of cemented control implants. 
Implantation sites were surgically prepared as in the in vivo procedures. A pressurized 
cementing technique was applied. The implant was placed inside a short plastic tube and a 
layer (approximately 3 mm) of commercial bone cement (Palacos®, Heraeus Kulzer GmbH, 
Germany) was applied on the implant surface before implantation. The plastic tube prevented 
spreading of the cement during tightening of the central screw and pressurized the cement 
fixation. The plastic tube was removed before torsional loading to failure. Mechanical testing 
of the ex vivo implants was carried out in parallel with the in vivo implants.  
 
4.4. EVALUATION OF FUNCTIONAL RECOVERY 
 
The analytical methods applied in each study are summarized in Table 4.4. 
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Table 4.4. Applied analytical methods. 
 
Method Study I Study II Study III Study IV 
Static weight bearing   ●  
Dynamic weight bearing    ● 
Torsional testing ● ● ● ● 
pQCT ●  ● ● 
QCT   ● ● 
DXA ●   ● 
Histomorphometry ● ● ● ● 
BEI-SEM ● ● ● ● 
EDXA ● ● ● ● 
 
4.4.1. Postoperative follow-up  
 
The animals were allowed to move without any restrictions in their individual cages 
immediately following recovery from anesthesia and were inspected daily. 
 
4.4.2. Static and dynamic weight bearing 
 
Static weight bearing on both hind limbs, expressed as percentage of body weight, was 
measured by standard digital scales at monthly intervals (III). 
 
Dynamic weight bearing on the operated hind limbs (IV) was evaluated at monthly intervals 
at trotting speed over a force plate (force plate: Kistler type 9286AA, Kistler Instrumente AG 
Winterthur, Winterthur, Switzerland; software: Aquire version 6.50, Sharon Software Inc., 
Dewitt, MI, USA). At least three valid measurements were obtained and the average peak 
vertical ground reaction force was recorded.  
 
4.5. ANALYSIS OF IMPLANT OSSEOINTEGRATION 
 
4.5.1 Radiographic analysis 
 
The anatomic position of the implants was checked in lateral and anterioposterior radiographs 
(Bennet X-ray, Copiaque, NY, USA) postoperatively and at one, two, and three months (III–
IV) and after the harvesting of the specimens (I–IV) by lateral and craniocaudal radiographs. 
Radiographic implant loosening was defined as a progressive increase in radiolucent lines (≥ 
1 mm), a change in the implant position by more than 5 degrees, or breakage of the side-plate 
(III) or interlocking screws (IV). 
 
4.5.2. Biomechanical testing 
 
The strength of bone-implant incorporation was determined by a standardized torque test to 
failure. The specimens were thawed at room temperature and kept moist during testing. The 
locking screws were removed (II and IV), the central connecting part of the prosthesis was 
disassembled (III and IV), and the side plates were cut (III) in order to allow unrestricted 
rotational motion during testing. The proximal and distal stems were tested individually (III 
and IV). 
 
The specimen was rigidly fixed with screws on a U-profile holder (II) or into a hollow 
cylindrically shaped metal jig (I, III, and IV) mounted on a universal testing machine 
(Avalon Technologies, Rochester, MI, USA (II) or MTS-858 Mini Bionix, MTS Systems 
Materials and methods 
42 
Corporation, Eden Prairie, MN, USA (I-IV). The implant was positioned in the axis of 
applied torque. A constant rate of rotation (0.5 degrees/second) was applied until failure. The 
data from the load cell were sampled by a controlled data acquisition system at the frequency 
of 5 Hz.  
 
The applied torque and degree of rotation were continuously recorded and the maximum 
torque (Nm) was read from the load-displacement curve. The stiffness (Nm/deg) was 
calculated by dividing the maximum torque (Nm) by the change in angle (deg). The energy to 
failure was calculated as the total surface area underneath the torque-deformation curve. 
 
4.5.3. Peripheral quantitative computed tomography (pQCT) 
 
pQCT scanning was performed using Stratec XCT (Norland Stratec Medizintechnik GmbH, 
Pforzheim, Germany). The images were scanned with a voxel size of 0.1 x 0.1 x 0.5 mm3. 
pQCT imaging has been found suitable for following new bone formation around bioactive 
particles (Välimäki et al. 2005). In the revision stem experiment (I), the measured density of 
the most central perforating stem hole, expressed as mg/cm3, was compared with those of a 
standard area (4 mm2) in the adjacent cortical bone and periprosthetic intramedullary space. 
In study IV, pQCT scanning was performed to examine any differences in the density of new 
bone within the grooves of the coated and uncoated stems (Level 1 in Fig. 4.3D). Two 
reference sites were applied (Levels 2 and 3 in Fig. 4.3D). The averaged attenuation, 
expressed as cm-1, was measured for each ROI.  
 
4.5.4. Quantitative computed tomography (QCT)  
 
Quantitative CT imaging was performed in order to delineate any differences in the density of 
periprosthetic cancellous and cortical bone. Imaging was performed with a 2 mm slice 
thickness with metal-artifact minimization (Siemens Somatom Plus 4, Siemens AG, Munich, 
Germany). The regions of interest (ROI) (Fig. 4.4 for study III and Fig. 4.5 for study IV) 
were the callous bone in the periprosthetic space of bone grafting next to the tip of the stem 
and a predetermined level of the cortical bone next to the stem. The ROI for each 
measurement was 1 mm2 (equivalent to 21–24 pixels on a CT image), and the average of two 
or three measurements for each region, expressed as Hounsfield unit, was calculated. In the 
grafted bones with bioactive glass + bone graft, the measured CT density values described the 
sum effect of new bone and bioactive glass (Välimäki et al. 2005). Cancellous bone at the 
base of the femoral head served as the reference site of cancellous bone density. The 
thickness of the periosteal reaction was measured at defined sites. 
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Study III    Study IV 
 
            
 
Figure 4.4. QCT measurements of canine femurs with intercalary prostheses (III and IV). The 
schematic presentation (left) indicates the scan levels of interest. The corresponding CT images of an 
autografted (III) or a mixture of bioactive glass + allograft grafted (IV) femur are shown on the right. 
(A) Cancellous bone of the proximal femur, marked by circle, served as the reference site for bone 
density. (B & E) The scans at the level just proximal and distal to the tip of stems served as sites for 
density measurements of cortical bone (circles in cortical bone) and intramedullary new bone 
(circles in medullary bone). The average values of cortical and intramedullary sites were calculated. 
(C & D) The images at the level of the most central interlocking screw demonstrate the sites for 
measurement of the periosteal reaction (double-headed white arrow in study III and white arrows in 
study IV). 
 
4.5.5. Dual X-ray absorptiometry scanning procedures (DXA) 
 
Dual energy X-ray absorptiometry (DXA) measurement of peri-implant bone mineral density 
(BMD) was performed to evaluate bone remodeling around revision stems (I) and around 
segmental prosthesis stems (IV). Several studies have confirmed the high precision (mean 
0.4–1.8%) of DXA in the measurement of peri-implant BMD (Corten et al. 1997, Markel et 
al. 1993). A Hologic QDR 4500C bone densitometer (Hologic Inc., Waltham, MA, USA), 
calibrated with a phantom, was utilized. The specimens were mounted in a standard position 
for scanning. The proximal femur in study I was divided into seven regions of interest (ROI) 
(Fig. 4.5A) as suggested by Gruen et al. (1979) for human THA femurs. In study IV the 
proximal and distal femur was divided into six regions of interest (Fig. 4.5B). Regional 
BMDs, expressed as g/cm2, were determined for each ROI and the paired comparison of the 
equivalent ROI was performed. 
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4.5.6. Histomorphometry  
 
The specimens were fixed in 70% ethanol, dehydrated in a graded series of ethanol, cleared 
in xylene, and embedded in isobornyl methacrylate. In study II the embedded tibial bone 
specimens were sectioned in the cross-sectional plane transversely to the axis of implant 
grooves using a water-cooled, high-speed, low-feed saw with a diamond-impregnated blade. 
In studies I, III, and IV the femur specimens were sectioned in the cross-sectional plane. 
Sections at standard levels were obtained (Figs 4.1A, 4.1B, 4.3B, and 4.3D). At each level of 
sectioning, one side of the sectioned surface was analyzed by light microcopy 
histomorphometry and the other by scanning electron microscopy (SEM) including back-
scattered electron imaging (BEI), except in study II, in which BEI-SEM images were used to 
evaluate the pattern of new bone ingrowth, the formation of reaction layers and new bone 
affinity on the bioactive glass microspheres, and failure mechanisms at implant-bone 
interfaces caused by torsional testing. 
 
In study I, a computerized image analysis system (Digithurst MicroScale TC, Royston, UK) 
was applied to measure the rate of bone ingrowth (%) into the implant slots or holes (I) or 
grooves (II), defined as the fraction (%) of bone within the porous bioactive glass area 
available for bone ingrowth. The defined area of measurements started from the level of the 
implant surface to the depth of two millimeters inside a slot or a hole (I). Both ends of the 
perforating holes in the revision stems were measured and averaged (I). In study II, both 
grooves of each implant were measured and averaged. The measurement of bone ingrowth 
was performed for two areas (Fig. 4.6) of the groove (II). For measurements of the bone 
affinity index (I) of implants, the outer perimeters of the stems were manually outlined on 
digital images using image-edition computer software (CorelDraw 9.0, Corel Corp. Ottawa, 
Ontario, Canada). The bone affinity index was also determined for bioactive glass granules 
used as bone graft extender (I) or the outer perimeters of glass microspheres at the opening of 
the implant grooves (II). The amount of bone in apposition to metal implant or to the glass (= 
affinity index) was calculated as a percentage of the sum of the pixels in line fragments to the 
sum of the pixels comprising the perimeter using an image analyzing program (PGT/MIX, 
Princeton Gamma-Tech inc., Princeton, NJ, USA and MicroGOP 2000/S, ContextVision AB, 
Linköping, Sweden). 
 
Figure 4.5. (A) Seven regions of 
interest (ROI) adjacent to the 
proximal sheep femur implant (I) 
used in DXA. (B) Six regions of 
interest (ROI) in DXA adjacent to the 
canine intercalary prosthesis (IV). 
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In studies III and IV, histomorphometric measurements were performed on digital images of 
the stained sections. The areas of interest were selected (Fig. 4.7) or outlined using image-
editing computer software (Adobe Photoshop version 7.0, Adobe Systems Inc., San Jose, CA, 
USA), and the measurements were performed using custom-designed software. The 
following parameters were measured: the amount of new bone and number of bioactive glass 
granules in the periprosthetic medullary space (Levels 1, 2, and 3 in Figs 4.3B and 4.3D), 
expressed as a percentage of the cross-sectional medullary area, the amount of new bone in 
the grooves of the implant (Levels 1 (III and IV) and 2 (III)), expressed as a percentage of 
the groove area, and the affinity index of new bone (Levels 1 and 2), expressed as the per-
centage on the surfaces of the implant and bioactive glass granules. Two independent 
observers performed the histomorphometric measurements and the average value was 
calculated and applied. 
 
  
4.5.7. Scanning electron microscopy (SEM) with back-scattered electron imaging (BEI) 
and energy-dispersive X-ray spectrometer analysis (EDXA) 
 
For BEI-SEM imaging, one surface of each sectioning was coated with carbon with a 
Temcarb TB500 carbon coater (Emscope Laboratories Ltd., Ashford, UK). Imaging (LEO s 
360, Cambridge Instruments Ltd., Cambridge, UK and LEO 1530, Carl Zeiss AG, 
Oberkochen, Germany) was performed in order to visualize the pattern of new bone growth 
and bioactive glass incorporation as well as to study the failure mechanisms at the bone-
implant interfaces during torsional testing. After qualitative BEI-SEM analysis, an energy-
dispersive X-ray spectrometer analyzer (EDXA) was used to further verify the chemical 
bonding of the reaction layers of bioactive glasses with new bone. Using BEI-SEM/EDXA, 
element analysis was performed to obtain X-ray maps of sodium (Na), silicon (Si), calcium 
(Ca), and phosphorus (P) in the characterization of bioactive glass dissolution processes. 
Figure 4.6. Histomorphometric measurement 
areas A and B in the groove of a disc implant 
(with or without inlay) in study II. In the 
grooved control implants the groove was 
empty at the time of implantation. In the 
glass-inlayed test implants the groove was 
filled by porous glass. 
Figure 4.7. Histological evaluation areas of canine femurs with 
intercalary implants (III). Two of the three levels of histological 
sections indicated in the radiograph in Fig. 4.3B made through 
the proximal and distal stems. Corresponding representative 
histological section of a distal stem grafted with autogenous 
bone and bioactive glass (Level 2, van Gieson stain) 
demonstrating the stem of the implant in the medullary canal 
and peri-implant space filled with bioactive glass particles. The 
amount (percentage) of bone was measured in the medullary 
area (B+C) and in the grooves of implant (C). A = cortical bone, D 
= stem. 
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4.6. STATISTICAL ANALYSES 
 
Data were tested for a normal distribution and equal variances using the Kolmigorov-
Smirnov or Shapiro-Wilk’s test and Levene’s test, respectively. Data are presented as the 
mean ± SEM (I and III) or mean ± SD (IV), and as median values with ranges (II). 
 
In study I, the paired t-test was utilized in comparisons of test and control stems in the case of 
a normal distribution of the data. Otherwise, the nonparametric Wilcoxon signed-ranks test 
was applied.  
 
In study II the data were not normally distributed. Thus, intra-animal and inter-animal 
comparisons of multiple implant groups were performed with Friedman two-way ANOVA 
and Mann-Whitney U-tests, respectively.  
 
In study III the paired t-test was utilized in the analysis of differences between the two sides 
in static weight-bearing and QCT densities of new bone formation. The nonparametric 
Wilcoxon signed-ranks test was applied in comparisons of mechanical and histomor-
phometric results. 
 
In study IV, linear mixed model analysis (McCulloch and Searle 2001) was applied to 
analyze any significant effects and possible interactions of allograft-BG mixture grafting and 
bioactive glass coating on implant healing. In the case of significance, the differences were 
tested using a paired t-test, or the non-parametric Wilcoxon signed ranks test, if the criteria 
for parametric testing were not fulfilled. The paired t-test was utilized in the analysis of 
differences between the two sides and analysis of variance for repeated measurements at 
different time points in dynamic weight bearing. 
 
To test the reliability of the histomorphometric results of two separate observers, intraclass 
correlation was calculated in studies III and IV. 
 
A Bonferroni correction value was applied, when appropriate. The significance level of 0.05 
was applied. The analyses were performed using SPSS version 14.0 (I-III) or PASW version 
18.0 (IV) (SPSS Inc., Chicago, IL, USA). 
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5. RESULTS 
 
5.1. POROUS INLAYS OF BIOACTIVE GLASS MICROSPHERES 
 
Porous bioactive glass inlays in the macrotexture grooves, slot or holes of unloaded 
implant (I and II) did not give any advantage to titanium alloy implant incorporation in 
bone based on biomechanical and histological analyses. 
 
In study I, no significant differences were detected between simulated unloaded grit-blasted 
titanium alloy primary and revision stems with or without bioactive glass inlays in the sheep 
proximal femur in biomechanical testing. On histological sections of primary stem simulation 
(I) specimens, no or minimal new bone formation was observed within bioactive glass inlays, 
and there were no clear differences in the amount of new bone (range 1.6% to 3-6%) within 
the inlays filled different bioactive glasses (compositions 13-93, 1-98, 3-98). In revision stem 
simulation (I), histological sections showed significant new bone formation inside the porous 
bioactive glass inlays (Fig. 5.1). The average amount of new bone within porous bioactive 
glass inlays was 26.1 ± 2.2%, and there were no significant differences between the holes at 
different levels of the stems. In paired comparison in revision stem simulation (I), the 
specimens with the control stems and stems with bioactive glass inlays showed no significant 
differences in periprosthetic BMD values for different ROI in pQCT or DXA. 
 
 
 
Figure 5.1. Histological transsections (Van Gieson dye) of test implants with bioactive glass inlays in a 
slot of the simulated titanium alloy (Ti) primary stem (A) and in a hole in the simulated titanium alloy 
(Ti) revision stem (B) in the proximal sheep femur. A fibrous connective tissue capsule partly 
surrounds the stem in A. Direct bone-implant contact with the stem and bone ingrowth into a 
porous bioactive glass inlay in the hole of the stem is observed in the simulated revision study with 
peri-implant autogenous bone grafting (B). The porous bioactive glass shows signs of new bone 
formation in situ. 
 
In study II, grooved titanium and cobalt chromium alloy implants with bioactive glass inlays 
showed significantly lower torsional failure loads than the control titanium alloy implants 
with unfilled grooves at 12 weeks and 25 weeks (Fig 5.2). There were no significant 
differences in the torsional failure loads of titanium alloy implants with bioactive glass inlays 
compared with grit-blasted Ti6Al4V control implants, which represented the standard clinical 
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coating technology. The titanium and cobalt chromium alloy implants with 100% bioactive 
glass filled grooves had significantly (p < 0.05) higher failure loads than the cemented cobalt 
chromium alloy implants at 12 weeks. The composition of the bioactive glass inlay, i.e. the 
relative amounts of bioactive glass and biocompatible glass, did not significantly affect the 
torsional failure loads of titanium and cobalt chromium alloy implants at 12 weeks. There 
was a trend for higher failure loads in cobalt chromium alloy implants with 100% bioactive 
glass-filled grooves compared with those with 30% bioactive glass-filled grooves at 25 
weeks. The findings from BEI-SEM images (II) explained the major differences observed in 
mechanical incorporation of the implants. For implants with filled or unfilled grooves, there 
was a linear correlation between the median values of torsional failure loads and the median 
values of bone ingrowth in area A (r2 = 0.888) and in area B (r2 = 0.797). Implants with 
bioactive glass inlays showed some ingrowth of new bone at the opening (area A) of the 
grooves at 12 weeks, but the amount was low compared with the control titanium alloy 
implants with unfilled grooves, and the difference was even more distinct in the deeper parts 
(area B) of the implants (Fig 5.3).  
 
 
 
Figure 5.2. The torque to failure (median values with two central interquartiles and 95% confidence 
intervals) of grooved bioactive glass-inlayed test implants was significantly lower than that of 
grooved control implants with unfilled grooves at 12 weeks and 25 weeks (significant differences are 
marked as follows: *** p < 0.001, ** p < 0.01, * p < 0.05). Outlier observations are presented as 
small circles. BG = bioactive glass, Ti = titanium alloy, CoCr = cobalt chromium alloy 
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Figure 5.3. Significantly less bone was present in the porous glass inlays of test implants (area A and 
B of Fig. 2) compared with the grooves of control implants at 12 and 25 weeks (significant 
differences are marked as follows: ** p < 0.01, * p < 0.05). (Median values with two central 
interquartiles and 95% confidence intervals.) Outlier observations are presented as small circles. BG 
= bioactive glass, Ti = titanium alloy, CoCr = cobalt chromium alloy 
 
5.2. MOLDED AND LASER-DEPOSITED BIOACTIVE GLASS COATING 
 
Molded (II) and laser-deposited (IV) bioactive glass coatings failed to improve bone 
incorporation of metal alloy implants and showed signs of detachment. 
 
Cobalt chromium alloy implants in sheep with a layered molded bioactive glass coating (I) 
showed no or minimal resistance to torsion in biomechanical tests and delamination and de-
attachment in histology. 
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Laser-deposited bioactive glass coating (IV) of canine intercalary prostheses had a significant 
retarding effect on implant healing, regardless of the type of bone graft used. Under torsional 
testing, laser-deposited bioactive glass-coated stems showed a significantly lower maximum 
failure load (p = 0.023), smaller angle of deformation before failure (p = 0.015) and lower 
energy to failure (p = 0.004) (C and D in Fig. 5.3), and a significantly decreased affinity of 
new bone to the implant surface at Levels 1 and 2 (p = 0.021 and 0.017, respectively) 
compared with uncoated grit-blasted titanium alloy stems (A and B in Fig. 5.3). No 
significant differences were detected in the pQCT values of the implant surface grooves and 
in the periprosthetic BMD values measured by DXA. Similarly, the type of coating had no 
effect on the QCT density values of the medullary canal filled with a mixture of allograft and 
bioactive glass. In the femurs with allograft filling, the periprosthetic QCT values of the 
laser-deposited bioactive glass coated stems was higher (p = 0.040) than those of uncoated 
grit-blasted stems. This change was probably due to some detachment of the laser-deposited 
bioactive glass coating with a significant concomitant increase in the amount of medullary 
new bone. In most grooves of the laser-deposited bioactive glass-coated stems, there was no 
direct contact between new bone and the implant surface. EDXA revealed that the laser-
deposited bioactive glass coating of the implant grooves had reacted and formed areas of high 
calcium phosphate content without concomitant new bone formation, while there were also 
areas with dissolution of the bioactive glass coating. 
 
 
 
5.3. IMPLANT SURFACE MACROTEXTURE 
 
Macrotexture (groove) was more effective than microroughening (grit blasting) on the 
mechanical incorporation of titanium cortical implants in the sheep tibia.  
 
During torsional failure testing (II), the control titanium alloy implants with unfilled grooves 
already showed high failure loads (median 6.25 Nm) at 12 weeks (Fig 5.2). By 25 weeks, the 
failure loads of these implants had more than doubled (median 14.3 Nm). The unfilled 
grooves of the control titanium implants alloy were partly filled with new bone at 12 weeks 
(Fig. 3E), and almost completely filled by ingrown new bone at 25 weeks (Fig. 5.5). 
Morphometric measurements of the control titanium alloy implants with unfilled grooves 
confirmed that about half of areas A (median 55.3%) and B (median 43.5%) were filled by 
new bone at 12 weeks, and the amount of new bone increased by 25 weeks (p < 0.05), when 
over 80% of areas A (median 86.9%) and B (median 81.7%) were occupied by new bone. 
Figure 5.3.  Representative load-deformation 
curves in torsional failure testing. The grit-blasted 
stems with periprosthetic allograft or a mixture of 
allogeneic bone and bioactive glass grafting showed 
similar high resistance results (A and B, 
respectively), while the laser-deposited bioactive 
glass-coated stems with an identical periprosthetic 
graft (C and D, respectively) showed low resistance 
to torsional loads. 
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Above all, the unfilled grooves of the control titanium alloy implants already showed an 
osteonal compact bone structure at 25 weeks (Fig. 5.5), explaining the high increase in 
resistance to torsional loading. 
 
 
 
Figure 5.5. At 12 weeks, abundant bone ingrowth into the unfilled groove of a control titanium alloy 
implant with no inlay is evident. At 25 weeks, the groove with no inlay is almost entirely filled with 
new bone. 
 
5.4. BIOACTIVE GLASS GRANULES AS A BONE GRAFT EXTENDER 
 
Under the physiological high loading conditions of the current canine model, filling of the 
periprosthetic medullary space with bioactive glass granules as a bone graft extender could 
not compensate for the inhibitory effect of mechanical micromotion on the healing of 
standard grit-blasted implant stems. As the elasticity and viscoelastic deformation of 
ceramic particles is very small, it may lead to high local stresses between particles and the 
surrounding tissue. (III and IV) 
 
Bioactive glass granules appear to be an efficient bone graft substitute to partly (50%) 
replace or extend conventional autogenous or allogeneic bone grafting in a contained 
space outside the immediate load-bearing periprosthetic space and in non-loaded 
conditions. (I, III, and IV) 
 
In non-loaded revision stem simulation (I), the peri-implant regions of mixed bone grafting 
were still radiographically visible around revision stems at 25 weeks (Fig. 4.1). As a sign of 
bone incorporation, all revision stems (except one unstable control stem) exhibited moderate 
failure loads under torsional failure testing. The amount of new bone within the grafted 
region of the medullary canal was similar in the revision stems with bioactive glass inlays 
(11.8 ± 3.1%) and control stems (16.3 ± 6.7%). The bioactive glass granules showed bonding 
with new bone and incorporation with the trabecular network of cancellous bone. BEI-SEM 
images demonstrated the formation of two reaction layers on individual bioactive glass 
granules and well-mineralized new bone in direct contact with the outmost apatite layer of the 
bioactive glass surface (Fig. 5.6). The affinity index of new bone on the surface of bioactive 
glass granules in the medullary canal was 14.7 ± 2.3%.    
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Figure 5.6. To the left: BEI-SEM image showing a bioactive glass particle in tight contact with new 
bone in the medullary canal of the sheep femur in the simulated revision stem experiment. On the 
surface of the glass particle (BG), a dark silicon gel layer (rich in silicon) is seen and on the top of it a 
white CaP layer (rich in calcium and phosphorus) in tight contact with new bone. C = cortical bone, M 
= medullary new bone. To the right: Using BEI-SEM/EDXA, element analysis was performed to obtain 
X-ray maps of sodium (Na), silicon (Si), calcium (Ca), and phosphorus (P). 
 
Based on measurement of static weight bearing (III), the animals favored weight bearing on 
the autografted leg at one and two months, but equal weight bearing was observed at three 
months (Fig 5.7). Based on the radiographic and clinical criteria, eight out of the sixteen 
autografted implants and seven out of the sixteen composite-grafted implants appeared to be 
incorporated with bone at three months. In the proximal femur (III), the torsional strength of 
the composite of autogenous bone and bioactive glass grafted implants did not achieve the 
bonding strength of the implants packed with pure autogenous bone alone (p = 0.068). The 
torsional stiffness and other parameters of the mechanical incorporation showed similar 
differences between the two sides. In the distal femur, there were no significant differences 
between the two bone grafting procedures in the mechanical incorporation of the implants.  
 
 
 
Based on the force-plate measurements (IV), animals bore significantly less weight on the 
legs grafted with a mixture of bioactive glass and allograft compared to the allograft side at 
one (p = 0.045) and two (p = 0.003) months postoperatively (Fig 5.8). In repeated follow-up 
radiographs, the number of loosened stems in the femurs filled with allograft was 6 of 16 
Figure 5.7. The animals 
favored weight bearing on 
the autografted leg at one 
and two months, although 
the differences were not 
statistically significant. Equal 
weight bearing was ob-
served at three months. The 
plots present mean values ± 
SEM (n = 8).  
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(38%), and in the mixture of allograft and bioactive glass 4 out of 16 (25%). In torsional 
testing, these stems were mechanically unstable (torsional resistance ≤ 0.5 Nm) and were not 
included in further analyses. The type of bone grafting (allograft alone or allograft mixed 
with bioactive glass granules) had no significant effect on the mechanical incorporation of the 
implants or on the histomorphometric parameters of implant healing, and there was no 
interaction with the type of implant coating. In the periprosthetic space of the proximal 
components of the autografted implants (III), there was significantly more new bone in the 
medullary canal (Levels 1 and 2, p = 0.036 and p = 0.017, respectively), in the grooves of 
implant stems (Level 2, p = 0.036), and also an enhanced affinity of new bone (Level 2, p = 
0.046) compared with the implants grafted with a mixture of autogenous bone and bioactive 
glass in histomorphometry (III). The distal components of the autografted prostheses showed 
similar trends of enhanced new bone formation, but the differences were not statistically sig-
nificant. 
 
  
 
The type of bone grafting had no significant effect on either the pQCT (III and  IV) or the 
DXA (IV) density values of the periprosthetic bone regions. Due to high density of bioactive 
glass granules, medullary canal regions grafted with a mixture of allogeneic bone and 
bioactive glass  had significantly higher QCT density values compared with those filled with 
allograft alone (p = 0.044 between bioactive glass coated stems and p = 0.008 between grit-
blasted stems) (IV). There were no significant differences in the amount of medullary new 
bone (Level 3 in Fig. 4.3) between the two types of bone grafting (IV).       
 
BEI-SEM images demonstrated the failure mechanisms of implants with ingrown new bone 
under torsional testing. Typically, fracture lines next to the outer ridges of the implant texture 
were found (III and IV). Bioactive glass granules (I, III and IV) incorporated well with 
trabecular new bone, and EDXA demonstrated the formation of silica-rich and calcium 
phosphate-rich reaction layers on the surfaces of bioactive glass granules (Fig. 5.9).  
 
Figure 5.8. The animals bore 
significantly less weight on 
the legs grafted with a 
mixture of bioactive glass and 
allograft compared to the 
allograft side at one *(p = 
0.045) and two **(p = 0.003) 
months postoperatively. The 
plots present mean values ± 
SEM (n = 8). 
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Figure 5.9. EDXA verification of chemical bonding of reaction layers of the bioactive glass surface 
with new bone. Combined with BEI-SEM image analysis, linear X-ray mineral analysis was carried out 
along the scan line (white arrow) through new bone and an incorporated bioactive glass granule (A). 
The contents of Ca and P were predominant in the areas of new bone formation and also in the 
apatite reaction layer (double black arrows) of the bioactive glass surface. The silica-rich surface 
layer of the bioactive glass surface showed high peaks of Si. The core of the bioactive glass granule 
(between black arrow heads) showed constant levels of Si, Na, Ca, and P. 
 
5.5. ANIMAL MODELS 
 
The demanding healing conditions of the proximal sheep femur were characterized by 
failure of implant incorporation without adjunct bone grafting. 
 
In primary stem simulation (I), only three out of the nine primary stems with bioactive glass 
inlays and three out of the nine control stems showed discernable failure loads (range 0.7–5.2 
Nm) in torsional failure testing at 12 weeks. The rest of the stems were unstable and 
exhibited no or minimal (≤ 0.5 Nm) torsional resistance. In revision stem simulation (I), all 
revision stems (except one unstable control stem) exhibited moderate failure loads under 
torsional failure testing as a sign of bone incorporation at 25 weeks, and there were no 
significant differences in bone incorporation between the revision stems with or without 
bioactive glass inlays.  
 
In histological sections of primary stem simulation (I) specimens, there was a layer of 
trabecular new bone of various thicknesses surrounding the grit-blasted part of the primary 
stems in the cancellous bone region of the proximal femur. The unstable stems showed a 
narrow connective tissue interface between the implant surface and new bone.  
 
In histological sections of revision stem simulation (I) specimens, the fully grit-blasted 
revision stems with and without bioactive glass inlays had solid incorporation with trabecular 
new bone. Histomorphometry confirmed a relatively high affinity index of new bone on 
implant surfaces. The affinity index was similar at the different levels of the stems. 
 
The canine model presents a model of a very active animal. Thus, high rates of prosthesis 
loosening were detected in studies simulating an intercalary tumor prosthesis packed with 
bone graft. 
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In studies (III and IV) the animals were weight bearing on the first postoperative day. In 
repeated follow-up radiographs of canine intercalary prostheses, 15 stems out of the 32 (47%) 
in study (III) and 10 stems out of 32 (31%) in study IV fulfilled the radiographic criteria of 
loosening. Based on the radiographic and clinical criteria, eight out of the sixteen autografted 
implants and seven out of the sixteen composite-grafted implants appeared to be incorporated 
with bone at three months. 
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6. DISCUSSION 
 
6.1. POROUS INLAYS OF BIOACTIVE GLASS MICROSPHERES 
 
As shown in study I, bioactive glass-filled inlays failed to promote osseointegration of fully 
grit-blasted titanium alloy stems in the medullary cavity of the sheep femur. Study II, using 
disc implants on the cortical bone of the sheep tibia, confirmed our previous findings and 
definitely proved that porous inlays made of bioactive glass microspheres do not provide any 
measurable advantage in the mechanical incorporation of titanium or cobalt chromium alloy 
implants. The inlays did not improve the osseointegration of implants compared with 
macrotextured or grit-blasted implants.  
 
The hypothesis of studies I and II was that the successful promotion of osteogenesis in the 
bioactive glass filled inlays could improve the osseointegration of titanium implants. 
Hydroxyapatite coating has an established role in promoting the osseointegration of titanium 
implants. Compared with hydroxyapatite, bioactive glasses have several unique properties, 
including a controlled resorption rate (Brink et al. 1997), as well as the ability to promote 
new bone formation (Xynos et al. 2000), and to induce high local bone turnover (Välimäki et 
al. 2005). Despite early positive results (Griss et al. 1976), bioactive glass has failed as a 
conventional surface coating material of titanium implants in experimental studies (Lopez-
Sastre et al. 1998), and also in primary THA patients (Alonso-Barrio et al. 2004). Therefore, 
studies I and II utilized a different approach. Bioactive glass was applied as porous surface 
inlays. The main approach was to fit porous inlays sintered from bioactive glass microspheres 
into the slots, holes, or grooves of metal implants in order to protect them from mechanical 
damage during implantation and physiological loading. A rabbit model has suggested two 
different patterns of osteogenesis in porous bioactive glass bodies (Itälä et al. 2003a): 
appositional new bone formation in the implant interstices (i.e. bone ingrowth), as well as 
new bone formation in situ inside the implant interstices. In situ new bone formation within 
porous bioactive glass implants probably represents the direct invasion of mesenchymal stem 
cells. Bioactive glasses are known to possess the ability to stimulate mesenchymal stem cell 
differentiation (Xynos et al. 2000). Differentiation of mesenchymal stem cells within porous 
bioactive glass implants may follow through the chondrogenic or osteogenic pathway 
according to the anatomic site of implantation (Ylänen et al. 1999). In studies I and II, an 
assumption was that in situ bone formation inside the bioactive glass inlays of a titanium 
implant might be advantageous by serving as initial anchorage points, facilitating the overall 
osseointegration of the implant. Evidently, this did not happen. The fully grit-blasted revision 
stems (I) implanted with mixed autogenous bone grafting healed, but the extent of new bone 
attachment over the whole implant surface was not promoted by the growth of new bone 
inside the bioactive glass filled inlays. The healing conditions were compromised due to the 
presence of adipocytic bone marrow, and adjunct autogenous bone grafting was needed for 
osseointegration of the stems. This was an undetermined cofounding factor in the analysis of 
the results. In order to re-evaluate our original concept, study II was designed to employ a 
simple large animal model for intra-animal comparisons of multiple implants under 
standardized healing conditions. Both studies came to the same conclusion, despite major 
differences in the experimental models. No clear advantage was gained by the use of the 
bioactive glass inlays of this type in the macrotextured implant surface. The result of studies I 
and II demonstrate that the concept does not work. 
 
The three different glass compositions tested belong to the system of Na2O-K2O-MgO-CaO-
B2O3-P2O5-SiO (Morshed et al. 2007, Brink et al. 1997). Previously, the in vivo behavior of 
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the glass 13-93 (Välimäki et al. 2005, Itälä et al. 2003a, Ylänen et al. 1999) has been 
characterized, and the two modified compositions (1-98 and 3-98) were developed to 
improve the working properties of the glass, for example, in the creation of microspheres. 
The biological response to three bioactive glass compositions was expected to be similar, as 
was observed in study I. Similar finding were reported by Itälä et al. (2003a). The bioactive 
glass microspheres showed an expected bioactivity on BEI-SEM images (I and II), and in 
study II the inlays made of 100% bioactive glass microspheres worked better than the 
composites made of sintered blends of bioactive and biocompatible glass microspheres in the 
promotion of bone ingrowth. 
 
6.2. LASER-DEPOSITED BIOACTIVE GLASS COATING 
 
A CO2 laser-fixed bioactive glass coating on titanium implants did not prove to be functional 
in heavy loading conditions. The laser-deposited bioactive glass coating of a cementless 
intercalary reconstruction failed to promote osseointegration and even reduced new bone 
affinity on the grit-blasted surface of titanium alloy, and impaired the mechanical 
incorporation of the implant. 
 
The poor osseointegration of the laser-deposited bioactive glass coated stems (IV) 
contradicted the results reported in an unloaded rabbit model (Moritz et al. 2004a). There are 
two possible explanations for the difference: the mechanical detachment of the laser-
deposited bioactive glass coating was caused by heavy physiological loading conditions or 
excessively rapid bioactive glass dissolution. Bioactive glass coating was not generally found 
to remain, but in the areas where it was found the thickness of the (originally) three-layer 
coating was seen to exceed 100 µm at best, which might have created high loads on the brittle 
material. Moritz et al. (2004b) reported an approximate coating thickness of 30 µm, as did 
Borrajo et al. (2007). A coating thicknesses of 1 mm was achieved by laser cladding 
(Comesaña et al. 2010). Comesaña et al. (2010) reported 52 wt% silicon-containing glass to 
apply better in laser treatment than 45 wt% silicon-containing glass. In a recent study, 
bioactive glass of 1-98 composition in the form of woven glass fibers failed to demonstrate 
the previously observed positive effect on osteogenesis when used as sintered microspheres 
(Alm et al. 2010). The resorption rate of bioactive glass fibers was assumed to exceed the 
balanced rate of dissolution necessary for an optimal biological response. The same 
phenomenon might have occurred to a certain extent in the thin laser-deposited bioactive 
glass coating (IV). The formation of calcium phosphate-rich areas in the vicinity of the laser-
deposited bioactive glass coating indicates that the applied bioactive glass composition 
reacted in vivo, although this did not result in the expected biological response of new bone 
formation.  
 
6.3. IMPLANT SURFACE MACROTEXTURE 
 
A macrotextured surface on titanium alloy implants was found to be more effective than grit-
blasting in promoting mechanical incorporation (I). Trapezoidal grooves in an implant 
surface seem to be a way to improve the osseointegration of cementless implants to resist 
torsional forces. 
 
Different macrotextured surface designs including sintered beads, fiber metal meshes, 
grooves, ridges, dentations, slots, and holes have been applied in the cementless stems of hip 
arthroplasties as a goal to improve osseointegration as well as to provide immediate stability 
and long-term anchorage with ingrown bone. There is some experimental data that favor their 
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use compared with a grit-blasted surface (Friedman et al. 1996, Hirao et al. 2005). As a 
disadvantage, these textured surfaces can act as stress risers, leading to periprosthetic bone 
fracture or implant failure. In study II, the better than expected performance of titanium alloy 
implants with unfilled trapezoidal grooves was an incidental finding. The groove was not 
purposely designed to improve the mechanical interlocking of the ingrown new bone, but to 
hold the sintered porous bioactive glass inlays. However, the design and its dimensions 
seemed to provide the best means for biological and biomechanical incorporation to resist 
torsional forces. The trapezoidal groove could be an efficient adjunct in improving the 
performance of cementless stems, especially in revision hip arthroplasty. 
 
Grit-blasting is one of the standard clinical methods for surface microroughening of titanium 
alloy implants. The implants of the current study were microroughened by a clinical grit-
blasting method used for joint implants with long-lasting satisfactory performance based on 
joint register databases. Indeed, compared with the untreated smooth titanium alloy implants, 
microroughening induced mechanical osseointegration. However, the measured torsional 
failure loads of grit-blasted titanium alloy implants were not strikingly high (II), and the 
variation in the measured values was quite high at 12 weeks, which is considered to represent 
the normal healing time of hip prostheses. In comparison, the median of maximum torque 
values of the grit-blasted titanium alloy implants was only 25% of the median of maximum 
torque values of titanium alloy implants with unfilled grooves, and the lowest maximum 
torque value of titanium alloy implants with unfilled grooves (4.37 Nm) was at the same level 
as the highest value (4.61 Nm) measured for the grit-blasted titanium alloy implants. This 
comparison throws some doubt on the actual efficacy of microroughening to improve 
mechanical incorporation in terms of the ability to resist high torsional forces. 
 
6.4. BIOACTIVE GLASS GRANULES AS A BONE GRAFT EXTENDER 
 
Studies III and IV demonstrated the risk of biological failure in cementless weight-bearing 
prostheses if the periprosthetic space is filled with autogenous or allogeneic bone and small 
bioactive ceramic particles, although the effectiveness of this filling was proved in non-
loading conditions in study I.   
 
In the current study, clinically available grafts were used. A corticocancellous bone graft was 
obtained from the ileal wing in study III. In study IV with an improved tighter fitting 
prosthesis, the same size of bioactive glass granules was used but combined with a 
commercial bone graft with a slightly smaller granule size. When the bone graft is packed 
under load, the graft of larger bone chips will have less subsidence under pressure and less 
recoil after release of pressure in comparison with the graft of small bone chips (Ullmark and 
Nilsson 1999, Dunlop et al. 2003, Cornu et al. 2009, Giesen et al. 1999). The dimensions of 
the peri-implant space limited the use of medium or large-sized bone chips. Nevertheless, 
particle size was not found as important for subsidence and recoil with a processed bone graft 
in comparison with a fresh-frozen graft (Cornu et al. 2009). Bioactive glass granules mixed 
with an autogenous bone graft failed to improve the implant incorporation in study III. The 
implants grafted with a mixture of autogenous bone and bioactive glass showed an earlier 
start of radiographic loosening and there was a trend to less spontaneous weight bearing on 
the side grafted with a mixture of autogenous bone and bioactive glass at one and two 
months. A previous canine study has shown that static and dynamic weight bearing are 
sensitive indicators of the inherent stability of a healing bone (Aro et al. 1991). Supporting a 
trend in study III, study IV confirmed a significant decrease in spontaneous weight bearing 
on the side grafted with a mixture of allograft and bioactive glass granules. Thus, it is evident 
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that supplementation of periprosthetic autogenous or allogeneic bone graft with bioactive 
glass granules may reduce implant stability. It was clear that grafting the mixture with 
allograft and bioactive glass granules (IV) did not significantly decrease the rate of 
mechanical loosening, even in the presence of reduced physiological loading. On the other 
hand, bioactive glass granules did not seem to change the path of osseointegration and the 
outcome was similar by three months (IV). Despite CT-based optimization and modifications 
of the implant design, the uncoated grit-blasted stems showed a considerable rate (38%) of 
mechanical loosening (IV). Using this model, it was advantageous to examine whether a 
mixture of corticocancellous bone graft and bioactive glass would improve the initial stability 
of the stem and thereby reduce the failure rate. According to Brewster et al. (1999), ceramic 
bone graft substitutes mixed with morselized bone allograft may provide an optimal 
distribution of particle size and improve the initial implant stability under optimal in vitro 
testing conditions. Thus, the use of a bone graft with a wide distribution in particle size is a 
regime where smaller particles filling the voids between larger particles are expected to 
increase stability (Karlsson and Spring 1970) according to the principles of soil mechanics. 
The current study failed to confirm the concept. The situation is obviously different under 
dynamic loading conditions when ceramic granules mixed with a bone graft can drastically 
change the mechanical properties of the graft (Verdonschot et al. 2001, Walschot et al. 2010). 
The elasticity and viscoelastic deformation of ceramic particles are very small, which may 
lead to rather high local stresses between the particles and the surrounding tissues. Indeed, 
this was the most likely mechanism of action behind the adverse reaction in the composite-
grafted implants. The results of studies III and IV indicate that bioactive glass granules could 
act as a rolling surface for implant micromotion under physiological loads. Oakley and 
Kuiper (2006) also found that cohesion between particles was lower in a mixture of allograft 
and calcium phosphate bone graft extender compared with pure allograft bone particles. 
However, the addition of clotted blood to the graft was reported to increase the cohesion of 
both bone graft particles and porous bone graft extender granules (Oakley and Kuiper 2006, 
van Haaren et al. 2005). Although a higher proportion than half of the graft extender has been 
proposed to be possible to use in impaction bone grafting with cemented THA (Blom et al. 
2005, Oonishi et al. 2001), the application of pure bioceramic particles as a graft in contact 
with the prosthesis is difficult, as brittle and low-adherent particles may pulverize under load 
and create high peak stresses during packing of the surrounding bone if impacted (Arts et al. 
2005). According to Walschot et al. (2010), a suitable biomaterial used around an implant in 
load-bearing areas of contained bone defect should be deformable and ductile. The porous 
and elastic material used in such a graft would prevent peak stresses at the interface of both 
an implant and the surrounding bone, allowing vascularization and the invasion of bone 
tissue. 
 
Outside the immediate peri-implant space, bioactive glass granules seemed to work as 
expected (I, III, and IV), but even in this region the amount of new bone tended to be below 
the level measured in autografted bones (III). Bioactive glass has been successfully used for 
clinical purposes in non-weight-bearing conditions (Lindfors et al. 2010a). 
 
6.5. ANIMAL MODELS 
 
These studies did not directly investigate the differences between sheep and dogs, but there 
appears to be a difference between these two species in endosteal bone formation in the 
medullary canal (Keränen et al. 2003). Bone formation in the sheep medullary canal was 
compromised in primary stem simulation and was greatly reinforced by grafting with a 
mixture of allogenous bone and bioactive glass (I). This compromised bone formation might 
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be caused by the abundance of yellow bone marrow and depletion of osteogenic cells in the 
area. The proximal sheep femur is anatomically characterized by a minimal amount of 
trochanteric cancellous bone and the presence of yellow adipocytic bone marrow. Korda et al. 
(2008), Coathup et al. (2008), and Blom et al. (2005) emphasized that the geometry of the 
sheep femoral cavity is also tubular and the bone is similar to sclerotic bone encountered in 
revision THA patients. Nevertheless, Coathup et al. (2008) also pointed out that the sheep 
model lacks some features of the tissue environment of revision total hip replacement in 
humans, including residual inflammatory tissue, endosteal erosions and the poor quality of 
host bone. El-Warrak et al. (2004) successfully presented an aseptic loosening model by 
creating a primary cement mantle defect, but an ethical hindrance prevails concerning the use 
of this model as a revision model, since second surgery is needed. Red bone marrow, which 
is known to be a rich reservoir of mesenchymal stem cells, is converted into the yellow fatty 
marrow of fluid consistency during early adulthood in sheep. Adipocytic bone marrow may 
not provide sufficient numbers of mesenchymal stem cells, preosteoblasts and osteoblasts, 
which are required for the biological process of bone ingrowth in the osseointegration of 
titanium implants. Indeed, Sachse et al. (2005) have found that adipocytic bone marrow of 
aged sheep creates highly compromised implant healing conditions. The current results 
confirmed their observations. In revision stem simulation (I), an osteogenic environment was 
created by bone grafting the implantation area after pressure lavage of the reamed proximal 
medullary canal of the sheep femur. The medullary canals were opened using 10 mm reamers 
and the simulated primary and revision stems were of the same size. Reflecting cortical 
contacts at the piriformis fossa and at the isthmus region, insertion of both stem designs 
required considerable force. However, because of the anatomic features of the proximal sheep 
femur, the straight stems provided no anatomic filling and a considerable empty peri-implant 
space was left for bone grafting. Therefore, the model can be considered as simulating the 
implantation of fully coated revisions stems. The stability of fully porous-coated revision 
stems is based on cortical bone-implant contacts (Reikerås and Gunderson 2006). Two 
different patterns of osteogenesis in porous bioactive glass bodies were observed in the 
present study in bioactive glass inlays in the medullary canal implants of the proximal sheep 
femur after adjunct bone grafting, and in 100% bioactive glass inlays of sheep cortical 
implant grooves in the periosteal tibial site: appositional new bone formation into the implant 
intertices (i.e. bone ingrowth), as well in situ new bone formation inside the implant 
intertices. Similar finding has been obtained in a rabbit model (Itälä et al. 2003a). Overall, the 
demanding healing conditions of the proximal sheep femur, characterized by the failure of 
titanium alloy implant incorporation without adjunct bone grafting, may apply well for a 
preclinical screening of new revision implants.  
 
Previous experiments on intercalary prostheses of the canine femur have mainly employed 
cement fixation (Okada et al. 1988, Virolainen et al. 1999, Young et al. 1997, Senaha et al. 
1996) because of the challenges in achieving stable cementless fixation in high loading 
conditions (Virolainen et al. 2005). The aim of studies III and IV has not been to mimic any 
particular clinical condition, but merely to test the osseointegration of cementless stems under 
high loading conditions, which represent the worst-case scenario. In the clinical 
reconstruction of a large segmental defect using a megaprosthesis (Bruns et al. 2007), 
periprosthetic bone grafting is not a standard procedure, but in revision cases empty 
periprosthetic cavities of non-contact areas could be amenable to additional bone grafting 
(similar to that performed in studies III and IV). Heck et al. (1986) studied tissue ingrowth 
into a cementless porous-coated titanium intercalary implant in the canine femur and found 
that supplementary fixation is needed. The shape of the intercalary prostheses (III and IV) 
was optimized according to CT-based modeling, and supplemented with side-plates and/or 
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interlocking screws and bone grafting. Even after these improvements, only eight autografted 
implants out of sixteen (50%) showed successful radiographic and mechanical incorporation 
(III). Skurla et al. (2005) found a similar (63%) high incidence of aseptic loosening in the 
femoral components of canine cemented total hip replacements. They suggested that, while 
the dog remains the animal model of choice for total hip replacement, the clinical 
performance of canine total hip replacements is more representative of that in young 
physically active human patients.  
 
Cementless fixation has been applied in the segmental replacement prostheses of tumor 
patients (Mittermayer et al. 2002, Werner et al. 2005), because cement fixation techniques 
have shown progressive loosening due to stress shielding. The key factor for the success of 
cementless stems is initial stability based on cortical contact. Periprosthetic bone grafting is 
not a standard procedure in these implants, but in revision cases empty periprosthetic cavities 
of non-contact regions could be amenable to grafting procedures. Because of the inherent 
tendency for mechanical loosening, the current model can be considered useful to examine 
whether grafting with a mixture of bone graft and bone graft substitute could improve the 
initial stability of the implant, according to laboratory studies (Brewster et al. 1999), and 
thereby reduce the failure rate. 
 
6.5. STRENGTHS AND LIMITATIONS 
 
Studies I-IV had inherent advantages in applying a large animal model, a clinical grit-
blasting method and torsional testing method of incorporation resembling physiological 
loading conditions. Torsional failure testing was utilized in the evaluation of mechanical 
incorporation of the implants with bone.  
 
A limitation of study I was that it applied an unloaded model, as non-loaded models may not 
be appropriate in the evaluation of ceramic bone graft substitutes, because as shown in study 
III, ceramic particles may act as a rolling surface for the micromotion of uncemented 
implants under dynamic loading conditions. There was no time sequence follow-up of 
implant healing and no comparison with hydroxyapatite-coated implants was performed. The 
follow-up times of primary and revision stems (I) were matched with the clinical equivalents 
of expected healing times, and no direct comparison between the two could be performed. 
Since the revision study also lacked a control group of bone grafting without bioactive glass, 
the significance of the bioactive glass component in mixed bone grafting could not be 
evaluated.  
 
It is possible that the slots of the primary stem (I) failed to work because of the lack of 
dynamic tissue fluid circulation within bioactive glass microsphere bodies. Zhang et al. 
(2008) have recently found that, at least under in vitro conditions, fluid circulation is essential 
for the activation of deep layers of bioactive glass granules. Therefore, perforating holes were 
used in the revision stem (I) in order to promote free tissue fluid flow between bioactive glass 
granules within the holes. Although perforating holes are certainly less ideal for the 
macrotexture of a clinical stem because of compromised fatigue strength, the selection of the 
model seemed to be justified in testing the study hypothesis. Nevertheless, this does not 
change fact that the implant incorporation in primary stem simulation without bone grafting 
was inferior to revision stem simulation with bone grafting in a sheep model due to fatty bone 
marrow. 
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Study II had inherent advantages in applying a large animal model, clinical titanium and 
cobalt chromium alloy alloys, a clinical grit-blasting method, and a physiological method for 
testing implant incorporation. As a limitation, the animal model was non-loaded and no 
comparison with hydroxyapatite coated implants was performed. In addition, the study lacked 
a time-sequence investigation of titanium alloy implants. 
 
Studies III and IV had inherent advantages in applying a physiological loaded large animal 
model, clinical titanium alloy, a clinical grit-blasting method and a physiological method for 
testing implant incorporation. The autogenous bone graft was selected in study III because it 
is the gold standard and its use provides the best possible healing outcome for the 
comparison. Commercial morselized canine allografts were used in study IV as an 
appropriate canine cortico-cancellous allograft. Despite the use of a large animal model, the 
dimensions of the peri-implant space limited the use of medium or large-sized bone chips and 
particles as recommended clinically. Under clinical conditions, mixing of larger bioactive 
glass granules with large cortico-cancellous allograft chips may indeed create a composite 
with different mechanical properties and probably also a different biological response in the 
peri-implant space. In this context, it should be recognized that, even in clinical cases, the 
anatomical dimensions of the proximal femur limit the use of larger cortico-cancellous 
allogeneic bone chips (Bolder et al. 2003). Because spontaneous physiological loading was 
dependent on the type of periprosthetic bone grafting, the comparison of implant healing 
under the two types of grafting may be questionable. However, it is clear that the mixtures of 
bone graft and bioactive glass used in the study could not significantly lower the rate of 
mechanical loosening, even in the presence of reduced physiological loading.  
 
As a potential limitation of the intercalary prosthesis model (III and IV), the proximal and 
distal stems of the prosthesis could be inter-dependent, and there was a risk that failure of one 
stem would affect the stability of the other. This phenomenon, however, was unlikely. If true, 
the expected outcome would not have differed between the two stems of the prosthesis in 
study IV (i.e. bioactive glass coated versus uncoated stems). The results suggested just the 
opposite. 
 
6.6. FUTURE DIRECTIONS 
 
Bioactive glass was investigated as a porous inlay or a CO2 laser-fixed coating material on 
the implant surface in the enhancement of implant incorporation (I, II, and IV), and as an 
extender of peri-implant bone grafting (I, III, and IV) in unloaded conditions in the proximal 
medullary canal (I) and on the cortex of the sheep tibia (II), and in loaded conditions in the 
diaphyseal medullary canal of the canine femur (III and IV).  
 
Although the clinical records of primary cementless titanium alloy stems with a 
microroughened surface are excellent (McLaughlin and Lee 2010), and the need for 
hydroxyapatite coating has even been questioned (Paulsen et al. 2007), the emerging trend 
among new clinical products is deeper roughening and the use of, for example, titanium 
microparticles on the surface. In these new coatings, the degree of roughening is completely 
different from the traditional ones originally developed for dental implants (le Guéhennec et 
al. 2007). The new surface treatments have been introduced by hip implant manufacturers not 
only to improve osseointegration but also to provide a rough surface for frictional resistance 
and initial mechanical stability. Little scientific literature is available on their biological 
performance. It would be of great interest and clinical importance to verify the efficacy of 
‘traditional’ and new roughening techniques using the experimental model of study I. As 
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shown, traditional microroughening seem to work well for primary hip stems in patients with 
good bone quality, but indeed the situation may be different for a coating of primary stems 
aimed at the increasing number of aged patients with impaired bone quality (Moritz et al. 
2011). 
 
Skurla et al. (2005) found a high (63%) incidence of aseptic loosening in the femoral 
components of the canine cemented total hip replacements. The clinical performance of 
canine total hip replacements is suggested as being more representative of that in young 
physically active human patients. Dogs show a tendency to forcefully and without restrictions 
use a fractured leg after operation in a clinical situation. Already nowadays, one of the 
clinically most used cementless canine hip implants relies on macrotexture features (screws 
and pegs) for initial fixation and bone ingrowth into surface roughness for long-term fixation 
into bone (Andreoni et al. 2010, Hummel et al. 2010). Further studies are needed to develop 
new solutions to new designs and surface textures of prosthetic implants. 
 
As shown in these studies, bioactive glass granules presented a risk when used as a bone graft 
extender packed around the prosthesis. The interlocking granules of tricalcium phosphate 
have been used as void filler (Field et al. 2009). A similar solution might work with a more 
load-bearing resistant substance when packed in the periprosthetic area while limiting granule 
migration. Osteoinductive and osteogenic bone graft substitutes have to be developed for 
tissue engineering purposes. The use of stem cells has already shown to be successful (Bruder 
et al. 1998, Frosch et al. 2003, Shih et al. 2005, Korda et al. 2008). Modifications of 
autologous mesenchymal stem cell implantation with graft materials loaded with cell 
adhesion proteins and mesechymal stem cells to enhance osteoinduction are still expensive 
and time consuming. In this field, there is a great need for research to improve the future use 
of growth factors and stem cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusions 
64 
7. CONCLUSIONS 
 
Based on these experiments, the following conclusions can be drawn: 
 
1. Implant surface inlays made of porous sintered bioactive glass microspheres or 
granules did not improve the mechanical incorporation of intramedullary grit-blasted 
titanium alloy stems and cortical titanium or CoCr alloy implants under unloaded 
conditions (I and II). 
2. Based on torque testing to failure, a macrotextured surface (trapezoidal surface 
grooves) was more effective than grit blasting (micro-roughening) in promoting the 
mechanical incorporation of unloaded cortical implants (II). 
3. Bioactive glass granules failed to act as a supplementation of periprosthetic 
autogenous bone grafting under high dynamic loading conditions in the segmental 
bone replacement model (III).  
4. In the segmental bone replacement model, spontaneous full weight-bearing was 
delayed on the limbs with periprosthetic bone grafting with a mixture of allograft and 
bioactive glass granules, suggesting that mixing of bioactive glass granules with 
morselized bone allograft may reduce initial implant stability (IV). 
5. The laser-deposited bioactive glass coating material reduced new bone affinity and 
impaired mechanical incorporation of grit-blasted titanium alloy stems in the 
segmental bone replacement model (IV). 
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